Study of hepatotoxicity induced by pyrrolizidine alkaloid-containing Chinese medicinal herbs. by Li, Mi. & Chinese University of Hong Kong Graduate School. Division of Pharmacology.
Study of Hepatotoxicity Induced by Pyrrolizidine 
Alkaloid-containing Chinese Medicinal Herbs 
LI Mi 
A Thesis Submitted in Partial Fulfilment 
of the Requirements for the Degree of 
Master of Philosophy 
in 
Pharmacology 
© The Chinese University of Hong Kong 
July 2008 
The Chinese University of Hong Kong holds the copyright of this thesis. Any 
person(s) intending to use a part or whole of the materials in the thesis in a proposed 
publication must seek copyright release from the Dean of the Graduate School. 
I ^ N j i j 
UNIVERSITY 
^ ^ ^ I B R A R Y s y s t e m x < ^ 
A B S T R A C T 
Naturally occurring pyrrolizidine alkaloids (PAs) are widespread both botanically 
and geographically. PAs are esters of alkaloids with either a saturated or an 
unsaturated necine base. PAs with the unsaturated necine base have attracted great 
scientific interest for several decades because they are responsible for hepatotoxicity 
in animals and human. Based on the different structures of the necine base, the 
unsaturated PAs are further classified into two types: retronecine type and 
otonecine-type. To date, more than 6000 plant species have been reported to contain 
PAs. Moreover, 49 plant species used as Chinese medicinal herbs in China and many 
other countries have been found to contain hepatotoxic (unsaturated) PAs. It is very 
likely that many more PA-containing medicinal herbs have not been identified. Many 
cases of hepatotoxicity in human have been reported to be induced by utilization of 
PA-containing Chinese medicinal herbs. Although the mechanism by which 
PA-induced hepatotoxicity has been studied extensively and the metabolic activation 
to form dehydropyrrolizidine alkaloid (also called pyrrolic metabolite), a unique 
toxic metabolite of different types of PAs, has been identified to play a main role in 
inducing hepatotoxicity, there are no suitable biomarkers available for the assessment 
of the PA-induced hepatotoxicity. Therefore, the aim of the present study was to 
investigate whether there is a correlation between the degree of PA-induced 
hepatotoxicity and the amount of liver tissue-bound pyrroles (the pyrrolic 
metabolite-protein adducts formed in the liver), and if such correlation exists, 
whether the liver tissue-bound pyrroles could be developed as a potential biomarker 
to assess the hepatotoxicity induced by PA-containing medicinal herbs. 
Firstly, two known retronecine-type PA-containing Chinese medicinal herbs, namely 
Crotalaria sessiliflora L. (Nongjili) and Gynura segetum (Lour.) Merr. (Jusanqi), two 
known otonecine-type PA-containing Chinese medicinal herbs, namely Ligularia 
hodgsonii Hook (Chuanziwan) and Tussilago farfara L. (Kuandonghua), and one 
Chinese medicinal herb containing both retronecine- and otonecine-type PAs, 
Senecionis scandentis Buch.-Ham. (Qianliguang), were selected for the present study. 
The identification and the quantification of PAs present in these herbs were 
i 
performed by H P L C - U V and H P L C - M S analysis. The qualitative results evidenced 
that all five herbs contained toxic PAs. Monocrotaline in Crotalaria sessiliflora L., 
seneciphylline and senecionine in Gynura segetum (Lour.) Merr., clivorine and 
ligularine in Ligularia hodgsonii Hook, senkirkine in Tussilago far far a L., 
seneciphylline, senecionine and senkirkine in Senecionis scandentis Buch.-Ham. 
were unequivocally identified. Furthermore, total content of toxic PAs in each herb 
were determined to be 16.4 mg/g dried herb (205.0 mg/g water extract), 2.6 mg/g 
dried herb (8.7 mg/g water extract), 0.8 mg/g dried herb (4.4 mg/g water extract), 
0.02 mg/g dried herb (0.12 mg/g water extract) and 6.95 |_ig/g dried herb (0.03 mg/g 
water extract) for Crotalaria sessiliflora L., Gynura segetum (Lour.) Merr., Ligularia 
hodgsonii Hook, Tussilago far far a L. and Senecionis scandentis Buch.-Ham., 
respectively, indicating relatively higher and lower contents of toxic PAs present in 
the former two and later three herbs, respectively. 
Secondly, male SD rats were utilized in the present study for the assessment of 
PA-induced hepatotoxicity. Animals were randomly divided into various groups (n = 
5) and orally administered with a single dose of each of the herbal extracts or pure 
PA (monocrotaline). At 24 hours after treatment, blood and liver samples were 
collected from the treated animals for the study. The general liver injury biomarkers, 
such as serum alanine aminotransferase (ALT) activity, hepatic levels of reduced 
form of glutathione (GSH) and apoptotic index of hepatocytes, were determined to 
examine the toxicity in the liver. Moreover, the characteristic hepatic morphological 
changes caused by PAs, including coagulative necrosis and hemorrhage, and amount 
of liver tissue-bound pyrroles, a specific and unique parameter only available with 
PA exposure, were also measured. In addition, in order to study the sub-acute toxicity 
effects, changes in liver to body weight ratio and liver weight, elevation of serum 
ALT activity, alteration of hepatic G S H level, and morphological changes of 
hepatocytes, were also assessed within 2 weeks after a single dose treatment of 
different PA-containing herbal extracts in rats. 
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Hepatotoxicity study in rats showed the extracts of Crotalaria sessiliflora L. and 
Gynura segetum (Lour.) Merr. caused liver injury dose-dependently, while even at 
the highest dose tested, the extracts of Ligularia hodgsonii Hook (10 g/kg), Tussilago 
ii 
farfara L. (10 g/kg) and Senecionis scandentis Buch.-Ham. (6 g/kg) did not exhibit 
significant hepatotoxicity mainly due to the low content of all toxic PAs in the herbs. 
The amount of liver tissue-bound pyrroles increased dose-dependently while their 
formation rates varied with different PAs present in herbs. Furthermore, regardless of 
the structures of PAs present in the herbs, amount of liver tissue-bound pyrroles 
correlated well with the percentage elevation of A L T activity, which was directly 
related to degree of the hepatotoxicity induced by PA-containing Chinese medicinal 
herbs. In addition, such a correlation was also further confirmed with a pure 
PA, —monocrotaline. The results demonstrated that regardless of PA structures, 
amount of the liver tissue-bound pyrroles correlated well with the PA-induced 
hepatotoxicity, although the degree of liver injury induced by PA-containing herbs 
varied significantly in different structures and contents of PAs present in individual 
herbs. 
Base on the correlation between hepatotoxicity (percentage elevation of A L T activity) 
and the formation of the liver tissue-bound pyrroles established from the 
PA-containing herbs tested, especially Crotalaria sessiliflora L. and Gynura segetum 
(Lour.), it was suggested that 1.2 jumol/g was estimated as a threshold amount of the 
tissue-bound pyrroles in the liver and a dose of any PA-containing medicinal herb 
generating the liver tissue-bound pyrroles higher than such amount may have a high 
risk to cause acute liver injury. In addition, a dose of PA-containing medicinal herbs 
forming 1.5 jumol/g of the liver tissue-bound pyrroles can be considered as an acute 
toxic dose. 
Therefore, the results obtained from the present study demonstrated that the liver 
tissue-bound pyrroles is a good biochemical parameter directly correlated to PA 




啦咯裏西卩定生物驗（pyrrolizidine alkaloids, PAs)作爲一種天然產物’廣泛 
分佈於植物界中。PAs的基本結構爲necine base。其中，含有不飽和necme base 
結構的PA可對動物和人類產生強烈的肝毒性。根據所含不飽和necme base的 
結構類型，毒性PA被分爲兩種：retronecine型和otonecine型。迄今爲止，研 













首先，用 H P L C - M S和 H P L C - U V的分析方法，對五種已知的含毒性 P A s 
的中草藥，農吉禾丨J ( Crotalaria sessiliflora L.) ，菊二七(Gynura segetum (Lour.) 
Merr.)，川紫荒(Ligularia hodgsonii Hook)，款冬花（Tussilago farfara L.)和千 




三七含有 seneciphylline 和 senecionine ,川紫舜含有 clivorine 和 ligularine，款冬 
花含有 senkirkine，千里光含有 seneciphylline ’ senecionine 禾口 senkirkine。it匕夕， 
； 每種中草藥中的毒性Ms的含量也被測得。其中，農吉利藥材中含毒性PAs 
— iv 
16.4mg/g,菊三七含2.6 mg/g,川紫荒含0.8 mg/g,款冬花含0.02 mg/g,千里光 













此外，liver tissue-bound pyrroles的產生也表現出明顯的劑量依賴性。不同的含 
PAs的中草藥產生liver tissue-bound pyrroles的速率不同。更値得注意的是，不 
論中草藥中含何種PAs，體內liver tissue-bound pyrroles形成的量與相應弓丨發的 
肝毒性均呈明顯的線性相關。此線性相關性由PA純品（monocrotalme)進一步 
證實。根據liver tissue-bound pyrroles的量與肝毒性之間的線性關係可得，當liver 
tissue-bound pyrroles在肝組織中的含量高於1.2网ol/g時，肝損傷可能在體內 
產生；當liver tissue-bound pyrroles在肝組織中的含量高於1。5 jumol/g時，顯著 
的急性肝毒性很有可能產生，而在肝中產生此liver tissue-boimd pyrroles量時使 
用的中草藥劑量，就是該種中草藥引發急性肝毒性的閩劑量。 
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A C N acetonitrile 
ALT alanine aminotransferase 
A N O V A analysis of variance 
CID collision induced dissociation 
C V central vein 
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D A B diaminobenzidine 
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ESI electrospray ionization 
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H & E haematoxylin and eosin 
H P L C High performance liquid chromatography 
H V O D hepatic veno-occlusive disease 
IPCS International Programme on Chemical Safety 
M H R A Medicines and Healthcare Products Regulatory Agency 
M S mass spectrometry 
PAs pyrrolizidine alkaloids 
PBS phosphate buffer solution 
R S D relative standard deviation 
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S E M standard error of mean 
SIM selected ion monitoring 
T C M traditional Chinese medicine 
TdT terminal deoxynucleotidyl transferase 
tR retention time 
U V ultraviolet 
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Chapter 1 Introduction 
1.1 Pyrrolizidine Alkaloids 
Pyrrolizidine alkaloids (PAs) are phytotoxins present in many plants throughout the 
world and are responsible for numerous livestock losses and human poisonings 
(Hirono, 1981). They are esters of the necine bases (Fu et al., 2004). Toxic PAs are 
esters of unsaturated necines (having a 1,2-double bond) whereas the ones with 
saturated necine bases are non-toxic (Figure 1.1). With the rapid growing interests in 
the use of natural products as medicines, dietary supplements and functional foods 
worldwide, it is now well recognized that some natural products, such as herbal 
plants, could induce adverse effect and toxicity in human. Undoubtedly, PAs are one 
of the most significant toxins in such natural plants. To ensure the medication 
security, the studies on PAs and PA-containing medicinal herbs became more and 
more important. Therefore, although PAs have attracted the views of scientists more 
than one century, during the recent several decades, the number of literature 
references relating to these topics increased dramatically. 
l.Ll Distribution and Plant Sources 
PAs are found in plants growing in most environments and all parts of the world, 
although those growing in warmer climates often have higher alkaloid levels 
(Mattocks, 1986). The toxic PA-containing plants have been found in South Africa, 
Central Africa, West Indies, China, Jamaica, Canada, Europe, N e w Zealand, 
Australia, and the United States (Stegelmeier et ah, 1999; Steenkamp et al, 2000). 
The main plant sources of PAs are the families of Boraginaceae {Heliotropium, 
Trichodesma, Symphytum and most other genera), Asteraceae (Senecio, Eupatorium 
and other genera of the tribes of Senecioneae and Eupatoriae), Fabaceae (genus of 
Crotalaria) and Scrophul-ariaceae (genus of Castilleja) (Culvenor, 1978). To date, 
about 660 PAs have been identified from more than 6000 plants species and the 
1 
number of such species is equal to 3 % of the world's flowering plants (Hartmann et 
a/., 1995). In China, a total of 49 species of the PA-containing Chinese herbal plants 
have been identified. The families, genera, and species of these plants are 
summarized in Table 1.1 (Fu et aL, 2002). 
H O H 尸 H2OH H O H 尸 H2OH H O C H 2 O H 
a 5 C O 
CH3 
Platynecine Retronecine Otonecine 
Figure 1.1 The common necine bases of pyrrolizidine alkaloids. Platynecine: the 
saturated necine in non-toxic PAs; Retronecine and Otonecine: the unsaturated 
necines in toxic PAs。 
Table 1.1 List of the family, genus and species of the PA-containing Chinese herbal 
plants in China (Fu et al., 2002). 
Family Genus Species 
1. Orchidaceae Liparis 1. Liparis nervosa 
2. Fabaceae Crotalaria 2. Crotalaria albida 
(Leguminosae) 3, C. assamica 
\ 4. C. mucronata 
5. C. sesseliflora 
6�C. tetragona 
3. Boraginaceae Arnehia 7. Arnebia euchroma 
Cordia 8. Cordia myxa 
Cynoglossum 9. Cynoglossum amabile 
10. C. lanceolatum 
11. C. officinale 
12. C. zeylanicum 
Heliotropium 13. Heliotropium indicum 
Lappula 14. Lappula intermedia 
Lithospermum 15. Lithospermum erythrorizon 
4. Asteraceae Aferatum 16. Ageratum conyzoides 
(Compositae) Chromolaena 17. Chromolaena odorata 
Eupatorium 18. Eupatorium cannabinum 
19. E. chinense 
20. E. fortunei 
2 
21. E. japonicum 
Cacalia 22. Cacalia hastata 
23. C. hupehensis 
Crassocephalum 24. Crassocephalum crepidioides 
Emilia 25. Emilia sonchifolia 
Farfugium 26. Farfugium japonicum 
Gynura 27. Gynura bicolor 
28. G. divaricata 
29. G. segetum 
Ligularia 30. Ligularia dentata 
31. L.hodgsonii 
32. L. intermedia 
33. L. lapathifolia 
34. L lidjiangensis 
35. L. cymbulifera 
36. L. duiformis 
37. L. vellerea 
38. L. tongolensis 
39. L. tsanchanensis 
40. L. heterophylla 
41. L. platyglossa 
Petasites 42. Petasites japonicus 
Senecio 43. Senecio argunensis 
44. S. chrysanthemoides 
45. S. integrifolius van fauriri 
46. S. nemorensis 
47. S. scandens 
Syneilesis 48. Syneilesis aconitifolia 
Tussilago 49. Tussilago far far a 
\ 
\A2 Structures and Nomenclature 
PAs are heterocyclic compounds, most of them are esters of basic alcohols, known as 
the necine bases. Thus, the hydrolyzed products of PAs are a necine base and a necic 
acid. In chemical terms PAs are complex, aliphatic, hydroxylated fatty acid esters 
that exist as monoesters, diesters or cyclic diesters. 
The necine base consists of the characteristic bridgehead nitrogen atom containing 
bicyclic heterocycle that in the saturated form is systematically named as 
pyrrolidine)[l,2-Q:]pyiTolidine or trivially as pyrrolizidine. However, most PAs are 
3 
derivatives of 1 -methylpyrrolizidine (where the methyl substituent is 
non-systematically numbered as the 9-position), for instance heliotridane, rather than 
pyrrolizidine itself (Figure 1.2). Therefore, in almost all cases, the necine base has 
hydroxyl groups at positions of C7 and C9. In esterification，hydroxyl groups are 
encountered in various positions, but positions of C7 and C9 are the most important 
with respect to toxic PAs. These hydroxyl groups are usually esterified with a necic 
acid giving monoester, open-chain diester, or macrocyclic diester alkaloids。 
Many different necic acids can form the acid moiety of pyrrolizidine alkaloids。They 
are mono- or dicarboxylic acids with branched carbon chains, bearing as substituents 
hydroxy, epoxy, carboxy, acetoxy, methoxy or other alkoxy groups。Moreover, 
numerous structural stereoisomers may often be formed (Mattocks, 1986). 
According to whether the ring of necine moiety is saturated or unsaturated (having a 
1,2-double bond), PAs are categorized into two types, called 'saturated' PAs and 
'unsaturated' PAs。The ones with saturated necine base are nontoxic, while the 
unsaturated ones can induce hepatotoxicity in humans and livestocks. Furthermore, 
the unsaturated PAs can also be classified into two types: retronecine type [or 
heliotridine-type, a 7(5)-isomer of retronecine type] and otonecine-type (Figure 1.2). 
In the case of the otonecine-type PAs, the necine base has a distinctive structure in 
that it appears to exist as the 8-membered hexahydroazocine heterocyclic ring system. 
Moreover, previous study suggested that there is a trans-annular interaction between 
the N-4 and C-8 of the necine base, thus otonecine-type PAs exist in a changed form 
(Klasek et al., 1967). In addition, a ^ H- and '^C-NMR spectroscopic study conducted 
by some others in our group have demonstrated that clivorine and ligularine, two 
typical otonecine-type PAs, exist in two different forms in different media。As shown 
in Figure 13, they exists with the necine base in the non-ionized 8-membered ring 
form with N-CH3 and O O groups when dissolved in organic solvents while in 
hydrophilic, ionized form with a bond of CH3-N4+-CrO- when dissolved in water 
(Mattocks, 1986). 
For practical purposes, PAs are usually known by their trivial names which are 
derived from the names of their source plants. Systematic chemical names are 
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unwieldy and rarely used. However, Culvenor et al. (1971) also introduced a useful 
rule on the systematic naming of PAs。Briefly, PA is named as pyrrolizidine if the 
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1.2 PA-containing Chinese Medicinal Herbs 
Since the land area of China extends from the arctic to the tropical climatic zone, a 
dramatically large number of plants are growing in the country. Thus, it is not 
surprising that Chinese have a long history of using plants and their preparations as 
Traditional Chinese Medicine (TCM) to treat illness even since 2200 years ago 
(Roeder, 2000). Many people in other Asian countries also take T C M for clinical 
practice or improving health for a long time。Over the past 30 years, interest in T C M 
also increased considerably not only in Europe but also in North America and 
Australia. 
Since the early 1950s, there are some articles published in the Chinese literature 
reporting the identification of PAs in Chinese herbal plants (Zhao et al” 2000). 
However, in the early times, the most famous scientists on this field are not Chinese, 
two of the specialists worked on PA-containing Chinese medicinal herbs are 
Germans: Roeder E. and Edgar J.A.. In 1992, Edgar et al estimated that possibly 
over 50 Chinese herbal plants contain PAs (Edgar et al�, 1992). Recently, after 
collected data from different research groups, a total of 49 species of the Chinese 
herbal plants have been identified (Table 1。1, Fu et al., 2002). All these plants are 
listed in Traditional Chinese Dictionary published in 1979 and used as T C M herbs in 
China. However, among these 49 PA-containing Chinese medicinal herbs, there is 
only one plant species, Senecio scandens (Chinese name: Qian Li Guang), that is 
documented to be officially used as the plant source for T C M herbs in the latest 
edition of China Pharmacopoeia (2005 Edition). But till now, the remaining 48 
PAs-containing Chinese medicinal herbs are still used as the plant sources for the 
locally used T C M herbs in different areas in China. 
Moreover, it is highly possible that many more Chinese medicinal herbs may contain 
PAs but have not yet been well characterized. Thus, human health risk induced by 
comsumption of such herbs and their products has to be a serious concern. 
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1.3 PA-induced Toxicity 
Many different PAs exhibit a variety of toxic actions in various species of laboratory 
and farm animals, as well as human beings. The consequences of PA poisoning 
include many diseases in human, such as hepatic veno-occlusion disease, pulmonary 
arterial hypertension, right ventricular hypertrophy, gastrointestinal lesions, and 
central nervous system disorders (Mclean et al, 1980; Huxtable, 1989). However, in 
this part of the description, the PA-induced toxicities are classified into four types as 
followed: acute and chronic toxicity, genotoxicity, tumorigenicity and hepatotoxicity. 
1.3.1 Acute Toxicity and Chronic Toxicity 
There are studies proved that sufficiently large doses of most toxic PAs can cause 
rapid death which happens in a few minutes to a few hours after PA intake. This type 
of toxicity, referred to peracute. The mechanism of peracute toxicity was not 
associated with cytotoxic action, but related to pharmacological changes of the body 
and the death may be preceded by convulsions or by coma. Peracute toxicity is often 
encountered when PAs are absorbed rapidly, such as after i.v. injections, and it was 
considered to be averted by injecting very slowly or by dividing the dose into several 
lots, separated by short time intervals. The more lipophilic PA and its pyrrolic 
metabolite, the more potential of peracute death (Mattocks, 1986). 
The acute toxic action of PAs is mainly on the liver cells. The poisoning causes 
massive hepatotoxicity with hemorrhagic necrosis. The potency of acute 
hepatotoxicity varies markedly among PAs (Mattocks, 1986). 
Chronic poisoning takes place mainly in liver, lungs and blood vessels. Sometimes it 
is also found in kidneys, pancreas, gastrointestinal tract, bone marrow and brain. 
Exposure over a long period of time, even just with a low dose, can cause cell 
enlargement, veno-occlusion in liver and lungs, nuclei enlargement with increasing 
nuclear chromatin, loss of metabolic function, inhibition of mitosis, fatty 
degeneration, proliferation of biliary tract epithelium, liver cirrhosis, nodular 
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hyperplasia, and adenomas or carcinomas (Roeder, 1995). The progressive nature of 
chronic PA intoxication have been mentioned by Bryan et al. who suggested that low, 
chronic PA exposure has cumulative effects (Stegelmeier et al., 1999). 
1.3.2 Genotoxicity 
Pyrroles, which are toxic PAs metabolites, are potent alkylating agents that can 
quickly bind with available cellular nucleophiles. They have been observed binding 
with genomic D N A and nuclear proteins, which exhibit the genotoxicity (Petry et al‘, 
1984). After that, a variety of genotoxicities including D N A binding, D N A 
cross-linking, DNA-protein cross-linking, sister chromatid exchange, chromosomal 
aberrations, mutagenicity, teratogenicity and carcinogenicity can be induced (Brink, 
1982; Carballo et al., 1992). 
1.3.3 Tumorigenicity 
Although some PAs have been demonstrated to have antitumor activity (Culvenor, 
1968), the mechanistic studies indicated that the retronecine-and otonecine-type PAs 
could induce tumors via a genotoxic mechanism mediated by 
6,7-dihydro-7-hydroxy-1 -hydroxymethyl-5//-pyrrolizine(DHP)-derived D N A adduct 
formation (Muller et al., 1992). 
1.3.4 Hepatotoxicity 
Although the PA-induced hepatotoxicity has been described in 1.3.1, as the main 
topic of this thesis, the hepatotoxicity will be reviewed here with some more details. 
PA-induced liver disease was first described in cattle in 1906 (Cushny, 1911). 
Thereafter, in 1920, clinical investigators in South Africa first reported hepatic 
fibrosis and sinusoidal engorgement resulting from ingestion of PAs in humans, and 
recognized the abnormalities of the central vein (CV) and the centrilobular 
localization of the damage (Willmot et al., 1920). These findings were later 
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confirmed by researchers in Jamaica where people ingested 'bush teas' prepared 
from leaves of PA-containing plants, Crotalaria fulva, and formed liver damage. 
After that event, the term of 'hepatic veno-occlusive disease' ( H V O D ) was bom 
(Selzer et al, 1950; Bras et aL, 1954). Nowadays, H V O D becomes a highly 
distinguished characteristic of PA poisoning. Because apart from PAs intoxication, 
only chemotherapy with drugs such as cytarabine, which is infrequently encountered, 
can cause H V O D。 
H V O D is a disease of the small branches of the hepatic veins which become 
occluded, leading to ascites, edema, and reduced urinary output. H V O D sometimes 
was misdiagnosed as Budd-Chiari syndrome and the major distinctive feature of 
H V O D is the involvement of the smaller hepatic veins, whereas, the Budd-Chiari 
syndrome is differentiated by the involvement of the occlusion of the larger hepatic 
veins, as well as thrombi formation. Besides that, in H V O D , the occlusion is not the 
primary event since the initial damage is to the hepatic parenchymal cells (Deleve et 
aL, 1999). H V O D exhibits a high mortality, and may lead to cirrhosis even if the 
patients survived。 
H V O D has been clinically divided into three stages: acute, sub-acute and chronic。 
The acute phase involves hepatomegaly and ascites, and is short lasting. Either 
remission or progression to the subacute stage follows, where the latter involves 
persistent firm hepatomegaly with recurrent ascites. Finally, the chronic phase is 
characterized by cirrhosis and liver failure (Huxtable, 1989). 
1.3.5 Mechanism of Toxic Effects 
Similar to the majority of other kinds of toxins, PAs require metabolic activation to 
exert toxicities. Determination of PAs metabolic activation pathways, and the 
metabolites, has been extensively studied. Thereby, the formation of the active 
metabolites -- pyrrolic esters has been determined to play the key role in PA-induced 
toxicity. 
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1.3.5.1 Metabolic pathways 
In phase I metabolism, there are three principal metabolic pathways for 
retronecine-type PAs. The first pathway is hydrolysis of the ester functional groups 
linked to the C7 and C9 positions to form the necine bases and the necic acids。The 
second pathway is TV-oxidation of the necine bases to the corresponding PA A^-oxides. 
The third one is the oxidation via two steps, hydroxylation of the necine base at the 
C3 and C8 position to form the corresponding 3- or 8- hydroxynecine derivatives 
followed by spontaneous dehydration to produce the corresponding 
dehydropyrrolizidine (pyrrolic ester) (Fu et al., 2004). The metabolism of riddelliine, 
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Figure 1.4 Principal phase I metabolism pathways of riddelliine (Fu et al., 2004) 
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The first two pathways, ester hydrolysis and TV-oxidation, are considered as 
detoxification routes, because all of the metabolites (necine bases, necic acids and PA 
iV-oxides) produced by these ways are more aqueous soluble than the parent PAs and 
can be excreted from urine or bile more easily. However, TV-oxides may also play a 
role in toxicity although they do not form toxic metabolites directly. This is because 
the iV-oxides can be enzymatically reduced in the liver and/or gastrointestinal tract 
back to the parent PAs, which can later be converted to pyrrolic metabolites 
(Mattocks, 1968). The third pathway, which generates pyrrolic esters is the only 
route proven to be associated with toxicity. 
The structure of the necine base of otonecine-type PAs is different from that of 
retronecine-type, thus the phase I metabolic pathways of the otonecine-type PAs are 
also different from those of retronecine-type. There are only two general principal 
metabolic pathways involved (Lin et al., 1998)。 First one is the hydrolysis of the 
ester functional groups to form the corresponding necine bases and acids, which is 
the same as retronecine-type. Second one is the formation of the corresponding 
dehydropyrrolizidine (pyrrolic ester) which is through oxidative A^-demethylation of 
the necine base and followed by ring closure (by elimination of a formaldehyde 
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Similar to that of retronecine-type PAs, the route of ester hydrolysis appears to be 
detoxification pathways, whereas the formation of pyrrolic ester leads to various 
toxic effects. 
The oxidation or oxidative A^-demethylation of different types of PAs to pyrrolic 
esters results in electrophilic activation of the C7 and C9 positions via conjugation 
with the pyrrole lone pair at nitrogen atom. These two sites are hence prone to 
nucleophilic attack and lead the pyrrolic esters to become highly reactive to undergo 
further biotransformations. Thus the pyrrolic esters can alkylate nucleophilic tissue 
components, such as -^ '-protein and -A^-DNA, to produce the dehydropyrrolizidine 
(DHP)-derived protein and DHP-derived D N A adducts (Figure 1.6). These 
tissue-bound adducts may remain in the body for quite a long time and thereby the 
toxicity is induced (Hincks et al., 1991; Kim et aL, 1995). On the other hand, it is 
well established that the pyrrolic esters not only combind with tissue components, 
but also soluble nucleophiles, such as glutathione (GSH). This phase II glutathione 
conjugation catalyzed by glutathione ^ -transferases is generally considered as the 
detoxification pathway to generate aqueous soluble products which can be easily 
eliminated from the body (White, 1976). However, the characteristics of the long 
half-life and water-soluble of G S H derived pyrrolic esters make it more or less as a 
‘reservoir’ compounds。These compounds may escape from excretion and migrate 
via the bloodstream or bile to reach and damage other tissues. Some people reported 
that the PA-induced lungs disease is elicited likely after cysteine-conjugate 
/5-lyase-dependent bioactivation or release of the G S H (Yan and Huxtable, 1994). 
Besides the above direct nucleophilic reaction, some of the pyrrolic esters may be 
further hydrolyzed to less reactive pyrrolic alcohols (DHP). They can also alkylate 
nucleophiles in tissue but in a slow and selective manner. Moreover, D H P also has 
long half-life and are capable of damaging tissues outside of the liver (Buhler and 
Kedzierski, 1986). 
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13.5.2 Liver tissue-bound pyrroles 
Due to the high reactivity, once the pyrrolic esters formed, they can rapidly bind with 
the nucleophilic tissue constituents firstly in liver and blood, such as -^ '-protein 
or —7V-DNA, to induce toxicities as described above. Thus the metabolic formation of 
the pyrrolic esters has been shown to be the primary metabolic activation responsible 
for the toxicities (Fu et al., 2004). Because of the significance of the pyrrolic esters 
in the PAs metabolism, they should be a good biomarker for the assessment of 
PA-induced toxicity. Unfortunately, the high reactivity towards nucleophilic 
compounds and so short aqueous half-life as several seconds (Mattocks, et al�, 1990a) 
of the pyrrolic esters make them undetectable, although the existence of the pyrrolic 
esters as metabolites of PAs have been confirmed by Glowaz et al using the 
synthesized dehydromonocrotaline (Glowaz, et al., 1992). Therefore, in the present 
study, we aim to develop the liver tissue-bound pyrroles, formed from the reactive 
pyrrolic esters combind with nucleophilic compounds on liver tissue, which is much 
more stable than pyrrolic esters (even can be detected in blood of rats treated with a 
single dose of monocrotaline after 4 weeks of treatment, Mattocks eL al., 1990b) to 
be a biomarker to assess the degree of PAs-inducing hepatotoxicity. 
The pyrrolic esters are electrophilic compounds capable of alkylating all types of 
nucleophilic tissue constituents. However, a comparison of the acid-catalysed 
reactivity of various nucleophiles with dehydroretronecine — a pyrrolic alcohol 
resulting from the hydrolysis of pyrrolic esters derived from retronecine-based PAs — 
showed that thiols group were by far the most reactive of the physiological 
compounds tested (Mattocks, et cd., 1983). Thus the tissue thiol groups are probably 
major targets of the reactive pyrrolic esters and the thiol groups-binding pyrroles are 
the main determination objects in the present study. As to the structure of the liver 
tissue-bound pyrroles, all of the three possible structures, 7-thioether, 9-thioether and 
7, 9-dithioether, were all detectable in the liver tissue of rats treated with retrorsine 
and monocrotaline (Mattocks et. al., 1990b). However, some others also reported that 
the binding position of dehydromonocrotaline and the thiol groups were just at 
7-position had been demonstrated both in vivo and in vitro (Mattocks et aL, 1990b, 
Glowaz, et al., 1992). Furthermore, the thiol groups binding positions of the 
^-conjugates produced by pyrrolic esters were suggested to be determined by the 
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structures of the parent PAs (Mattocks, et al., 1992)。However, no matter what 
position the thiol groups bind with, the hepatotoxicity may be induced as long as the 
pyrrolic esters bind to liver tissue (Hincks et al, 1991)。 
1.3.5.3 Metabolizing enzymes 
As described above, the metabolic formation of pyrrolic esters is shown to be the 
main metabolic activation responsible for various acute and chronic toxicities, 
genotoxicity and tumorigenicity. On the other hand, the hydrolysis process in all 
types of PAs and the A^ -oxidation process in the retronecine-type of PAs as well as 
the glutathione conjugation in phase II metabolism are generally considered as 
detoxification pathways. Therefore, the metabolic balance between the pyrrolic ester 
formation and the detoxification pathways appears to be crucial in determining the 
toxicities of PAs. Thus, different types of metabolizing enzymes which catalyze these 
metabolic reactions play important roles in the PA-induced toxicities and were 
discussed below. 
1.3.5.3.1 Phase I metabolizing enzymes 
Many studies had confirmed that the metabolic formation of reactive pyrrolic esters 
was mainly catalyzed be cytochrome P450 enzymes (CYP450), especially the 
CYP2B and CYP3A isoforms (Fu et al., 2004). For example, Kasahara et aL 
pretreated rats with phenobarbital which is a well-known inducer of both CYP2B and 
CYP3A, then compared to the untreated rats. The results showed that the rate of 
metabolism of PAs from Phenobarbital-pretreated rats was much higher than that of 
untreated ones (Kasahara et al., 1997). The D H P formations of riddelliine and 
clivorine, represented the retronecine- and otonecine-type PAs condition respectively, 
had been studied by different researchers and found to be primarily catalyzed by the 
hepatic CYP3A metabolizing enzyme (Xia et aL, 2003; Fu et al., 2004). These 
results support that the CYP3A enzymes are the major metabolizing enzymes 
responsible for metabolic activation of most, if not all, of the toxic pyrrolizidine 
alkaloids. 
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Metabolism of retronecine-type PAs to the corresponding "-oxides is catalyzed by 
both CYP450 and flavin-containing monooxygenases (Chung and Buhler, 1995). The 
contribution of flavin-containing monooxygenases and CYP450 on the A^-oxide 
formation was determined to be species different (Williams et al., 1989)。For instance, 
TV-oxidation of senecionine to senecionine A^-oxide by microsomes of pig was mainly 
catalyzed by flavin-containing monooxygenases (Miranda et al., 1991)。In contrast, 
the metabolism of senecionine to senecionine 7V~oxide in guinea pig was catalyzed by 
CYP2B (Chung and Buhler, 1995). 
Moreover, the hydrolysis of the ester groups of PAs leading to the corresponding 
necine base and necic acid moieties is considered to be mainly catalyzed by liver 
microsomal carboxylesterases and also sometimes by liver cytosolic 
carboxylesterases (Fu et al., 2004; Buhler and Kedzierski, 1986; Dueker et al, 1992)。 
Hepatic microsomal carboxylesterases consist of multiple isozymes, which exhibit 
drastically different substrate specificities. There are three carboxylesterase isozymes, 
RLl, RHl, and RL2, in rat and two isoforms, GPLl and GPHl, in guinea pig (Fu et 
al, 2004; Hosokawa, et al., 1990). 
1.3.5.3.2 Phase II metabolizing enzymes 
In the hepatic metabolism of different types of PAs, conjugation of the reactive toxic 
pyrrolic esters with glutathione to form glutathione conjugates is the most important 
detoxification pathway in phase II metabolism。This conjugation can occur either 
enzymatically or nonenzymatically. A good evidence for the nonenzymatical 
conjugation was that the G S H derived pyrrolic esters were obtained in a buffer 
solution containing dehydroretronecine and glutathione but without any enzyme 
(Robertson et aL, 1977). The enzymes mediating the glutathione conjugation of PAs 
in the liver are generally recognized as both cytosolic and microsomal 
glutathione-5'-transferases (GSTs) (Castagnoli et al., 1997). The extent of 
contribution of the GST catalysis to glutathione conjugation varies with the 
difference of PAs structures. For the case of jacobine, GSTs were found to have no 
effect on the rate of glutathione conjugation (Dueker et aL, 1994). GSTs are a large 
family of structurally related proteins, with different GST isozymes catalyzing 
different substrates, but often with an overlapping specificity (Jakobsson et al” 2000). 
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rglutamyl-cysteinyl-glycine (GSH), a ubiquitous endogenous tripeptide glutathione 
was required as the cosubstrate for the GST-catalyzed glutathione conjugation (Fu, et 
a/., 2004). 
Hepatic G S H level was reported to affect the glutathione detoxification of PAs 
(White, 1976). Reduction of G S H contents in liver of rats had no effect on the release 
of total pyrrolic metabolites of monocrotaline。However, the biliary release of 
7-GSH-DHP significantly decreased, while the tissue-bound pyrroles in the liver 
significantly increased (Fu, et al., 2004). The results indicate that PA-induced 
hepatotoxicity may be more pronounced if the hepatic G S H level is very low. 
1.3.5.4 Species and gender specificity toward toxicity 
As same as other types of chemical-induced dysfunctions, the species and gender 
differences are observed in PA-induced toxicity. A good explanation for these 
differences is the variations in the balance between the metabolic activations to the 
toxic or less toxic pyrrolic metabolites such as pyrrolic esters and DHP, and the 
detoxification routes to nontoxic metabolites like hydrolyzed products and 
glutathione conjugates (Castagnoli et al, 1997)。Thus, the hepatic biotransformation 
has been confirmed mainly to contribute to this metabolic variation (Cheeke, 1994). 
Generally, cattle, horses, pigs, chickens, ducks, rats, and mice resemble humans and 
are susceptible to pyrrolizidine alkaloid intoxication, whereas sheep, goats, rabbits 
and guinea pig are resistant to pyrrolizidine alkaloid toxicity (Fu et aL, 2004). Many 
investigations on the retronecine-type PAs focused on the species difference showed 
that male rats are the most highly susceptible whereas guinea pigs are resistant to 
most of retronecine-type PAs intoxication except for jacobine (White et al., 1973; 
Chung and Buhler, 1995). In the case of otonecine-type PAs, the results are similar to 
that of retronecine-type and guinea pigs still escaped from clivorine intoxication (Lin 
et al, 2003). Thus, guinea pig became an interesting object of the PA intoxication. 
The repeated results demonstrated that due to the high esterase activity toward all 
types of PAs in guinea pigs, the rates of hydrolysis detoxification pathways were 
significantly higher than in other experimental animals, such as rats and mice。 
Moreover, a significantly low rate of toxic tissue-bound pyrroles formation was also 
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observed in guinea pigs treated with clivorine (a representative of otonecine-type 
PAs). These two aspects were determined as the key points to explain guinea pigs 
resistance to PA-induced toxicity (Prakash et al�, 1999; Lin et al,, 2003). On the other 
hand, jacobine, which can induce toxicity in guinea pig, was found to be detoxified 
by hydrolysis with a low rate in guinea pigs due to the low activity of the 
corresponding esterases (Chung and Buhler, 1995)。The result of jacobine supports 
the importance of metabolizing enzyme activities in PA intoxication. 
Gender difference in the susceptibility to PAs of different types was also reported. 
The male rat was reported to be more susceptible than the female rat to both 
retronecine- and otonecine-type PAs (Candrian et aL, 1985; Lin et al, 2003). One of 
the studies investigating this field was conducted by Lin et al. and showed that the 
metabolic activation of clivorine is primarily mediated by CYP3A1 and CYP3A2, 
two of which are isozymes expressing in male rats but with significantly lower levels 
in female rats (Imaoka et al., 1991). Similar results were also obtained from rats 
treated with retronecine-type PAs, monocrotaline and retrorsine, and the 
male-specific isozymes CYP3A1 and CYP3A2 as well as CYP2C11 were considered 
as the contributors to the marked gender difference in rats (Chung and Buhler, 1995). 
The variations of those key isozyme expressions in different genders lead to the 
difference of PA metabolic activation and thus the gender difference in rats. 
However, up to now, there is no report specific to the different susceptibility of 
humans to PA-induced toxicity. Although no evidence exhibits significant variations 
of human expressions of CYP3A4, the crucial metabolizing enzyme responsible for 
the metabolic activation of PAs in humans, the expressions of CYP3A4 in the liver 
varies in individuals and more frequently in different ethnic groups. Moreover, 
drug-drug interactions may also play a role in variations of CYP3A4 activity (Herrlin 
et al., 2000). All of those may induce the variations in the metabolism of PAs and 
thus the individual difference toward PA-induced toxicity. 
1.3.5.5 Structure-activity relationships 
Investigations of naturally occurring and synthetic PA analogues have demonstrated 
that certain minimum structural features are required for PAs to be metabolically 
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activated to produce potential hepatotoxicity. These necessary characteristics are 
illustrated in Figure 1.7 and described as follows (Mattocks, 1986): 
a. An unsaturated (3-pyrroline) ring is required whereas the pyrrolizidine (the 
saturated one) ring is not essential as demonstrated by its absence in synthetic 
analogues. 
b. The skeleton has at least one hydroxyl group (two is preferred) to attached to the 
pyrroline ring via one carbon atom. 
c. At least one of these hydroxyls is esterified. Monoester PAs are usually much less 
hepatotoxic than corresponding diesters; toxicity is still less if the 7-hydroxyl is 
absent; some macrocyclic diesters have the highest toxicity; synthanecine monoesters 
are not hepatotoxic. 
d. The acid moiety has a branched chain. PA esters with unbranched acids may still 
be hepatotoxic, but less strong。 
O Z b 
X 广 、 V ^ d r S 〇 乂 O C R ^ d 
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Figure 1.7 Essential structural features of (A) a PA and (B) a PA analogue necessary 
for hepatotoxicity (Mattocks, 1986) 
X: H or H O or R C O O . 
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The intensity of PA-induced hepatotoxicity is also related to various factors, such as 
lipid solubility, and structures of both the acid and necine moieties which contributed 
to the steric hindrance. 
The molecular structures of PAs are important in determining the balance between 
the toxic activation and detoxication routes, by controlling the accessibility of 
metabolic sites to the appropriate enzymes. There is evidence to suggest that the 
detoxication pathway of hydrolysis is limited if the access of corresponding enzymes 
to ester groups is restricted by steric hindrance (Mattocks, 1986). This hindrance can 
be caused by bulky carbon substituents, acyl substituents (such as acetoxy groups) in 
the acid moiety close to the ester linkage, or by o;/5-unsaturation which restricts the 
flexibility of the acid chain in the acid moiety. On the other hand, the type and 
location of hydroxy Is in the necine moiety are considered to influence the hydro lytic 
detoxication of PAs and when two ester groups are close together, hydrolysis is 
inhibited. It had also been found that pyrroles were formed as a result of microsomal 
hydroxylation at position of C8 rather than C3 on the PA mucleus (Mattocks and Bird, 
1983)。The most important targets of metabolism of PAs can be summarized in 
Figure 1.8。 
Hydrolysis 
R C〇 \ ^ ^ 〇 
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Figure 1.8 Proposed major sites of metabolic attack in PA。The structure is shown as 
the steric configuration (Mattocks, 1986) 
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1.4 Prevention of PA-induced Toxicity 
As we all know, PAs are of great public health significance and also economic 
importance since they induce various toxicities in humans and livestock. Thus, 
studies on how to deal with PA-induced toxicities have never been stopped. Till now, 
there are several approaches having been determined to modify PA-induced toxicities, 
such as reduction of the formation of toxic metabolites of PAs by inhibiting the 
enzymes involved in these formations, decreasing the concentrations of pyrrolic 
metabolites which can interact with tissue mucleophiles in body by increasing the 
amount of thiols, treating animals exposed to PAs with sucrose diet, picroliv, 
glycyrrhizin or 18/5-glycyrrhetinic acid (Allen et al., 1972; White, 1976; Mattocks, 
1972; Dwivedi et al., 1991; Lin et al., 1999). However, all of those approaches are 
only conducted in laboratory and up to now, no effectively specific method to treat 
PA-induced toxicities is clinically used。Moreover, it has been pointed out that 
actually nothing can be done to prevent damage once a toxic PA has been ingested, 
and the best way to protect humans and livestock is to prevent the ingestion 
happening in the first place (Dai et aL, 2007). 
1.4.1 Significance of Prevention in Humans 
In the world, a very wide range of plant is employed by people either medicinally or 
for food while PAs are present in many families of such plants。Moreover, cereal 
crops and grazing land are sometimes contaminated with PAs, and the alkaloids may 
also contaminate wheat, honey and other foods, and introduce to milk from cows 
feeding on these plants. Thereby, humans are easily attacked by PAs through 
ingestion of these foods (Fu et al., 2002). No doubt, there are some people attacked 
by PA-containing foods in different parts of the world, but probably they have not 
realized the risk around them. Moreover, some cases of H V O D induced by PA 
intoxication have been reported in different countries. For instance, in Germany, a 
preterm neonate was died due to the hepatic veno-occlusive disease induced by the 
ingestion of PA-containing herbal mixture of the mother. In the fetal liver, 
dehydrolycopsamine and dehydrointegerrimine (two metabolites of toxic PAs) were 
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detected (Rasenack et al., 2003)。Recently, a 62-year old woman also developed 
H V O D after ingestion of Gynura root in China (Dai et al., 2007). 
A more dangerous source of human exposure to PAs is the deliberate use of 
PA-containing plants such as T C M to treat various illnesses. Once the 
PA-intoxication was induced in patients who have already afflicted by some other 
diseases, the pathogenetic condition of them should be more complex and be hardly 
reversed. Thus the prevention of PAs intake in humans, no matter to food or drugs, 
become very important and has been highly concerned by scientists and doctors in 
different countries. 
1.4.2 Regulations Toward Preventing Toxicity Induced by PAs 
Because PAs present in foods and herbal medicines can result in human poisoning 
and death, in 1989, the International Programme on Chemical Safety (IPCS) 
determined that PAs are a threat to human health and safety (International 
Programme on Chemical Safety, 1989). Thereafter, several western countries have 
made regulatory decisions on the use of PA-containing herbal products. For example, 
in 1992, the Federal Health Department of Germany restricted "the manufacture and 
use of pharmaceuticals containing pyrrolizidine alkaloids with an unsaturated necine 
skeleton" and also described "the herbal plants may be sold and used only if daily 
external exposure to no more than 100 ]ig pyrrolizidine alkaloids and internal 
exposure to no more than Ijug per day for no more than six weeks a year" 
(Dharmananda, 2001). Since 2001, the use of unsaturated PA-containing herbs and 
botanical products, comfrey {Symphytum officinale) being the most notable example, 
are strictly controlled in most developed countries (Dharmananda, 2001). Since 2002, 
the Medicines and Healthcare Products Regulatory Agency ( M H R A ) of the United 
Kingdom has proposed increasingly severe restriction and eventually prohibition of 
the sale, supply and importation of unlicensed medicinal products containing Senecio 
species for internal use, on the concern that various Senecio species contain PAs 
( M H R A 2002, 2004, 2007). However, in China, to date there are no systematic 
investigations on the PA-containing medicinal herbs, and no regulations for the use 
of such herbs. 
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1.5 Aim of the Present Study 
As reviewed above, herbal plants as T C M sources were used for clinical practice in 
China and many other countries. Such plants are also prepared as functional foods 
and dietary supplements. Therefore, the quality control and quality assurance of 
T C M are important for human health. However, in the case of PA-containing 
medicinal herbs, unlike some western countries, there is no regulation set up by 
government to instruct the manufacture and clinical practice of such plants in China. 
Moreover, the more obvious danger is that a large number of folk herbal medicines 
have been confirmed containing PAs but are still clinically used in China. In order to 
make some endeavor to avoid the intoxication induced by PA-containing herbal 
medicines, in the present study, the following studies were conducted: 
1. Identify and quantify PAs present in Crotalaria sessiliflora, Gynura segetum, 
Ligularia hodgsonii, Tussilago farfara and Senecionis scandentis, five 
PA-containing medicinal herbs traditionally used in China, using H P L C - U V and 
H P L C - M S analysis. 
2. Study the hepatotoxicity induced by the above five herbs in the male SD rats by 
determining the following general biomarkers of hepatotoxicity: serum alanine 
aminotransferase (ALT) activity, hepatic glutathione (GSH) level, liver to body 
weight ratio, morphological changes of liver sections and apoptotic index of 
hepatocytes. 
3. Establish the correlation between amount of the liver tissue-bound pyrroles and 
degree of hepatotoxicity induced by five PA-containing medicinal herbs. 
4. Determine the dose threshold at which hepatotoxicity might be induced by 
PA-containing medicinal herbs based on the established correlation between 
amount of the liver tissue-bound pyrroles and degree of hepatotoxicity induced 
by PA-containing medicinal herbs. 
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Chapter 2 
Qualitative and Quantitative Analysis 
of PA-containing Chinese Medicinal Herbs 
In order to investigate the hepatotoxicity induced by PA-containing Chinese 
medicinal herbs, five herbs, namely Crotalaria sessiliflora ( f t ) ? Gynura 
segetum (^H-t：), Ligularia hodgsonii {]\ , Tussilago farfara (i^^ft) and 
Senecionis scandentis (千里光)，were collected from different locations in Mainland 
China. Crotalaria sessiliflora and Senecionis scandentis have long been used in 
traditional Chinese medicine for anti-tumor and anti-inflammatory respectively while 
Ligularia hodgsonii and Tussilago farfara are used as antitussive agents (Hu et al, 
1992; Ji et al,, 2008; Koh et aL, 2007; Liu et al., 2006). Moreover, Gynura segetum 
is a famous folk medicinal herb for hemostasis and detumescence in northern China 
(Chen et aL, 2007). Amongst them, Gynura segetum, Crotalaria sessiliflora and 
Senecionis scandentis were reported to contain retronecine-type PAs: seneciphylline, 
monocrotaline and seneciphylline respectively (Li et al, 2008; Roder et al,, 1992; 
Yuan et al, 1990). On the other hand, researchers found that the otonecine-type PAs 
such as clivorine and senkirkine were present in Ligularia hodgsonii and Tussilago 
farfara (Lin et al., 2000; Mroczek et al., 2002). The herb-selection was based on the 
different types of PAs in herbs and the availability of the standards of these PAs. In 
order to further study the dose-hepatotoxicity relationship, qualitative and 
quantitative analysis of these herbs is the first important step. Thus, in this chapter, 
the types of PAs present in these herbs and their contents were determined. 
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2.1 Materials and Equipments 
2.1.1 Herbal Materials 
Radices of Ligularia hodgsonii Hook and Gynura segetum (Lour.) Merr., herbs of 
Crotalaria sessiliflora L. and Senecionis scandentis Buch.-Ham., as well as flower 
bud of Tussilago farfara L. were obtained from different places in P. R. China. The 
former two were purchased from Sichuan and Anhui Province, respectively. 
Crotalaria sessiliflora was obtained from Hubei Province. The last two were both 
collected from Shanxi Province. All herbal samples were authenticated according to 
conventional pharmacognosy procedures. 
2.1.2 Chemicals and Solvents 
The reference compounds monocrotaline from Aldrich Chem. Co. (P.O. Box 355, 
U.S.A.), senecionine and seneciphylline from Extrasynthesese (Genay, France) were 
purchased. Senkirkine was kindly provided by Prof. Sam Fong Yau Li, Department 
of Chemistry, National University of Singapore。Clivorine was isolaed from 
Ligularia hodgsonii in our laboratory by using the previously established extraction 
method (Cui et al； 2000; Lin et al., 2000). 
Analytical reagent (AR) grade acetic acid (CH3COOH) and diethylamine and general 
purpose reagent (GR) grade aqueous ammonia solution (NH4OH) and hydrochloric 
acid (HCl) were supplied from B D H Laboratory Supplies (Poole, England), whereas 
A R grade dichloromethane (CH2CI2) was obtained from Merck (E. Merck, 
Darmstadt, Germany). In addition, H P L C grade acetonitrile (ACN) and methanol (E. 
Merck, Darmstadt, Germany) were used for H P L C analysis. 
2.1.3 Equipment and Instrumentation 
Beckman L7 Ultracentrifuge and Beckman Model J2-21 Centrifuge (Beckman, 
Germany) were used in the experiment. The herbal extracts were lyophilized using 
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Benchtop 3L Freeze-drier (VIRUS). Chromatographic analysis was carried out using 
a H P (Hewlett Packard) 1100 liquid chromatograph system with a Diode Array 
Detector (DAD) (Agilent Technology)。The qualitative analysis of the herbal extracts 
was conducted on the API 365 LC/MS/MS system from PE-SCIEX/Applied 
Biosystems. 
2.2 Preparation of Herbal Extracts 
2.2.1 Crude Herbal Extract 
For each herb, to obtain the crude herbal extract, the dried herb was chopped into 
small pieces and refluxed with distilled water (1:6, w/w) for 1 hour. The aqueous 
extract was collected. The same extraction procedure was repeated for two more 
times. Three warm extracts were combined and kept at 20 °C overnight. On the 
second day, the extract was centrifuged at 3,000 g for 10 min and the supernatant was 
dried under reduced pressure to give syrup, then further lyophilized to yield dried 
powders and stored at -20 for further studies。The yields for Ligularia hodgsonii, 
Tussilago farfara, Gynura segetum, Crotalaria sessiliflora and Senecionis scandentis 
were 20%, 17%, 30%, 8 % and 26% respectively. 
2.2.2 Total Pyrrolizidine Alkaloid Extract 
To obtain the extract with higher content of PAs, part of Ligularia hodgsonii, Gynura 
segetum and Senecionis scandentis water extract were further prepared to yield the 
total pyrrolizidine alkaloid extract. For each of the above herbal water extracts, the 
lyophilized powder was reconstituted into diluted hydrochloric acid (4% HCl, pH 
2-3). The solution was sonicated for 30 min and then centrifuged at 3,000 g for 10 
min. The supernatant was extracted with CH2CI2 for three times to remove 
non-alkaloid components. The resultant aqueous layer was adjusted to pH 9-10 with 
NH4OH, and then extracted with CH2CI2 for three times. The CH2CI2 extracts were 
combined and dried under reduced pressure by a rotary evaporator to give the total 
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PA extract, which was stored at 4。C for future use. 
2.3 Qualitative and Quantitative Analysis of Ligularia hodgsonii 
2.3.1 Methods 
2.3.1.1 H P L C - U V condition 
H P L C analysis was carried out on H P 1100 system equipped with a Waters 
Symmetry Cig column (5 jum, 150 x 4.6 m m ) coupled with a guard column (Waters 
Spherisorb S5 C N , 10 x 4.6 mm). The column temperature was maintained at 25 
The analytes were monitored at 230 nm. Mobile phase was composed of 1% 
CH3COOH (A) and methanol (B) with gradient elution as follows: 0-20 min, 
95%-60% A; 20-40 min, 60%-20% A; 40-50 min, 20%-20% A。The flow rate was 1 
ml/min。 
2.3.1.2 H P L C - M S condition 
The mass spectrum was operated in a positive ion mode with an electrospray 
ionization (ESI) interface. The temperature of nitrogen drying gas was 400 °C with 
the flow rate of 7 L/min. Ion spray voltage was 4000 V. The orifice and focusing ring 
voltage was 41 V and 130 V respectively for the in-source collision induced 
dissociation (CID) in both full scan and selected ion monitoring (SIM) conditions. In 
the full scan mode, the mass range was 100-800 (m/z). The chromatographic 
condition was the same as for HPLC-UV analysis. 
2.3.1.3 Calibration curve for clivorine 
A distilled water stock solution containing clivorine was prepared and diluted to five 
different concentrations to construct calibration curve。Each concentration was 
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performed in triplicate and the relative standard deviation (RSD) was taken as a 
measure of precision。Calibration curve was constructed by plotting the concentration 
of clivorine as a function of peak area of spiked clivorine at the selected wavelength. 
2.3.1.4 Recovery test 
The recovery test was used to evaluate the accuracy of the method. Clivorine (64 jig) 
were added to 15 m g of the crude extracts of Ligularia hodgsonii (containing 66 jug 
of clivorine) prior to H P L C - U V analysis. The resultant samples were then extracted 
and analyzed as described in Section 2.3.1.5. The mean recovery was calculated 
based on five assays and the relative standard deviation (RSD) was taken as a 
measure of precision. 
2.3.1.5 Sample test 
For the qualitative analysis with HPLC-MS system, the lyophilized powder of crude 
herbal extract (30 mg) was dissolved in 1 ml distilled water and filtered with a 0.45 
jum PTFE membrane filter prior to H P L C - M S analysis. For the total alkaloid extract, 
1 m g of alkaloid extract was dissolved in 1 ml of methanol and filtered with a 
0.45|Lim PTFE membrane filter prior to the H P L C - M S analysis. Each sample was 
analyzed in triplicate. 
For the quantitative analysis with H P L C - U V system, the sample preparation was the 
same as the qualitative analysis described above. Each sample was analyzed in 
triplicate. 
2.3.2 Results and Discussions 
2.3.2.1 Qualitative analysis of PAs in Ligularia hodgsonii 
Authentic clivorine was analyzed by H P L C - U V and H P L C - M S to provide the 
retention time (Ir), UV, and mass spectrometry data for the comparison with those of 
compounds present in Ligularia hodgsonii extract。The representative HPLC-UV 
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chromatogram at 230 n m and the electrospray ionization mass spectrum (ESI-MS) of 
clivorine are shown in Figure 2.1 (A) and Figure 2.2 (A) respectively. 
As shown in Figure 2.1 (A), clivorine (tR 16.8 min) was eluted as a sharp and 
symmetric peak under the optimized chromatographic condition. The full scan M S 
spectrum (Figure 2.2 (A)) exhibited an ion with the highest mass unit at m/z 406 
corresponding to the protonated molecular ion [M+H] + of clivorine and two specific 
fragment ions for otonecine-type PAs (at 150 and 168 m/z). These characteristic 
fragment ions are in good agreement with the previously established M S patterns on 
fourteen PAs (Lin et aL, 1998). 
Figure 2.1 (B) and Figure 2.2 (B and C) showed the representative H P L C - U V 
chromatogram (230 nm) and mass spectra of PAs in Ligularia hodgsonii crude 
extract respectively. With comparison of the tR and U V chromatogram of the 
authentic clivorine, peak 1 was preliminary identified to be clivorine. Moreover, 
H P L C - M S was used for further confirmation of peak identification. Based on the 
results present in Figure 2.1 and Figure 2.2, peak 1 was unambiguously identified to 
be clivorine。In the case of peak 2, due to the unavailability of the authentic 
compounds, its identity was determined by comparing the tR, mass and U V spectra 
data with the published data for known PAs found previously (Kavvadias et al, 
2000). In the present study, it was determined as ligularine which is also an 
otonecine-type PAs with the specific fragment ions for otonecine-type PAs at 150 
and 168 m/z. The structures of PAs and the characteristic fragment ions are shown in 
Figure 2.3 and Figure 2.4 respectively. 
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Figure 2.1. HPLC-UV chromatograms at 230 nm. Representative HPLC-UV 
cliromatogram of clivorine (A) and the representative cliromatogram of Ligularia 
hodgsonii extract (B). 
1: clivorine; 2: ligularine. 
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Figure 2.2. The representative mass spectrum of the authentic compound of clivorine 
(A), clivorine in Ligularia hodgsonii extract (B) and ligularine in Ligularia 
hodgsonii extract (C) obtained by HPLC-MS analysis. 
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Figure 2.4 Structures of the characteristic mass fragment ions specific to different 
types of toxic PAs. 
2.3.2.2 Calibration curve for clivorine 
As shown in Table 2.1, the calibration curve for clivorine showed good linearity (r^  
> 0.999) in the concentration range tested. The R S D value for each concentration is 
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2.3.2.3 Result of the recovery test 
As shown in Table 2.2, the obtained accuracy varied between 96.1% and 98.5% 
indicated a good accuracy of the method. R S D of 2.0% proved a good precision of 
the recovery test. 
Table 2.2 Recovery of clivorine in Ligularia hodgsonii extract 
Clivorine in Clivorine Clivorine ^ ^^^^ a Mean ± SD RSD^ 
Water Extract Spiked Determined 、 ,。/、 ，o/、 
/ 、 / 、 / 、 （Zo) { / o ) [ / o ) 
(^g) ( M (be) 
67.4 64.0 126.3 96.1 
65.3 64.0 125.6 97.1 
65.2 64.0 126.1 97.6 97.6 ± 2.0 2.0 
65.9 64.0 127.9 98.5 
66.6 128.6 98.5 
^Accuracy (%) = [1 - I Amount of clivorine determined — (Amount of clivorine in 
water extract + Amount of clivorine spiked) I / (Amount of clivorine in water extract 
+ Amount of clivorine spiked)] xlOO 
bRSD (%) 二 (SD/mean) xlOO 
2.3.2.4 Quantification of PAs in Ligularia hodgsonii 
The developed H P L C - U V analytical method was subsequently applied to determine 
the PA components both in the crude herbal extract and the total alkaloids extract of 
Ligularia hodgsonii. The quantity of each PA present in the extracts was summarized 
in Table 2.3. Due to the unavailability of the authentic compound of ligularine, the 
content of ligularine was only semi-quantified and calculated based on the calibration 
curve of clivorine. From the results, the amount of clivorine was found to be almost 
40 times higher than that of ligularine in both extracts. Thus, the hepatotoxicity 
induced by Ligularia hodgsonii might be mainly contributed by clivorine. Moreover, 
The content of PAs present in the total alkaloids extract (564 mg/g extract and 15.6 
mg/g extract for clivorine and ligularine respectively) was significantly higher than 
that of the crude herbal extract (4.27 mg/g extract and 0.11 mg/g extract for clivorine 
and ligularine respectively). The total alkaloids extract with high content of PAs 
would be useful for the animal treatment with high dose in the later study. 
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Table 2.3 Contents of PAs in each herbal extract 
M a or PAs m/z Content of PA in 
Herbal Extract . 」” ‘ ‘ 「、/!5丁"1+ the Extract (mg/g 
in the Extract 「M + HI 二 ^ ^ 
extract) 
Crotalaria sessiliflora �< ^^^ 〜严 r. 1 ..r ^  r i , Monocrotaline 326 205 
Crude Water Extract 
Gynura segetum Senecionine 336 2.79 
Crude Water Extract Seneciphylline 334 5.94 
Gynura segetum Senecionine 336 298 
Total Alkaloids Extract Seneciphylline 334 570 
Ligularia hodgsonii Clivorine 406 4.27 
Crude Water Extract Ligularine 408 0.11 
Ligularia hodgsonii Clivorine 406 564 
Total Alkaloids Extract Ligularine 408 15.6 
Tussilago farfara Senkirkine 366 0.12 
Crude Water Extract 
2.4 Qualitative and Quantitative Analysis of Tussilago farfara 
2.4.1 Methods 
2.4.1.1 H P L C - U V condition 
An Agilent 1100 system was employed with a Waters Symmetry Cig column (5 |Lim, 
150 X 4.6 m m ) coupled with a guard column (Agilent Zorbax 〇DS, 12.5 x 4.6 mm). 
U V absorption was measured by D A D at the wavelength of 220 nm. The mobile 
phase consisted of 0.03% diethylamine in distilled water and A C N (86 : 14, v : v). 
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The column temperature was maintained at 25 °C and the flow rate was 1 ml/min. 
2.4.1.2 H P L C - M S condition 
The mass spectrum was operated in a positive ion mode with an ESI interface. The 
temperature of nitrogen drying gas was 400 °C with the flow rate of 7 L/min. Ion 
spray voltage was 4000 V. The orifice and focusing ring voltage was 41 V and 130 V 
respectively for the in-source collision induced dissociation (CID) in both full scan 
and selected ion monitoring (SIM) conditions. In the full scan mode, the mass range 
was 50-800 (m/z). The chromatographic condition was the same as for H P L C - U V 
analysis. 
2.4.1.3 Calibration curve for senkirkine 
A methanol stock solution containing senkirkine was prepared and diluted to 
appropriate concentrations to build calibration curve. Each concentration was 
performed in triplicate and the relative standard deviation (RSD) was taken as a 
measure of precision. Calibration curve was constructed by plotting the concentration 
of senkirkine as a function of peak area of spiked senkirkine at the selected 
wavelength. 
2.4.1.4 Recovery test 
Senkirkine (5.8 |Lig) was added to the 50 m g of the water extract of Tussilago farfara 
(containing 6.0 \ig of senkirkine) prior to the analysis of H P L C system. The resultant 
samples were then extracted and analyzed as described in Section 2.4.1.5. The 
average recovery was calculated based on two assays. 
2.4.1.5 Sample test 
For the qualitative analysis with HPLC-MS system, the lyophilized powder of crude 
herbal extract (100 mg) was dissolved in 1 ml distilled water and filtered with a 0.45 
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)im PTFE membrane filter prior to H P L C - M S analysis. Each sample was analyzed in 
triplicate. 
For the quantitative analysis with H P L C - U V system, the sample preparation was the 
same as the qualitative analysis described above. Each sample was analyzed in 
triplicate. 
2.4.2 Results and Discussions 
2.4.2.1 Qualitative analysis of senkirkine in Tussilago farfara 
Authentic senkirkine was analyzed by H P L C - U V and H P L C - M S to provide the 
retention time (IR), UV, and mass spectrometry data for the comparison with those of 
compounds present in Tussilago farfara extract. The representative H P L C - U V 
chromatogram at 220 n m and the mass spectrum of senkirkine are shown in Figure 
2.5 (A) and Figure 2.6 (A). 
As shown in Figure 2.5 (A), senkirkine (tR 14.5 min) was eluted as well-defined peak 
under the optimized chromatographic condition. The full scan M S spectrum (Figure 
2.6 (A)) exhibited an ion with the highest mass unit at m/z 366 corresponding to the 
protonated molecular ion [M+H] + of senkirkine and two specific fragment ions for 
otonecine-type PAs (at 150 and 168 m/z). These characteristic fragment ions are in 
good agreement with those of clivorine and ligularine (both are otonecine-type PAs). 
Figure 2.5 (B) and Figure 2.6 (B) showed the representative HPLC-UV 
chromatogram (220 nm) and mass spectra of senkirkine in Tussilago farfara extract 
respectively. With comparison of the tR, U V chromatogram and mass spectrum of the 
authentic senkirkine, the peak (at 14.5 min) in Tussilago farfara extract was 
unambiguously identified to be senkirkine. The structure of senkirkine and the 
characteristic fragment ions are shown in Figure 2.3 and Figure 2.4 respectively. 
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Figure 2.5. H P L C - U V chromatograms at 220 nm. Representative HPLC-UV 
chromatogram of senkirkine (A) and the representative chromatogram of Tussilago 
far far a extract (B). 
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Figure 2.6. The representative mass spectrum of the authentic compound of 
senkirkine (A) and senkirkine in Tussilago farfara extract (B) obtained by H P L C - M S 
analysis. 
2.4.2.2 Calibration curve for senkirkine 
As shown in Table 2.1, the calibration curve for senkirkine showed a good linearity 
(r^  = 1) in the present concentration range. The R S D value for each concentration is 
lower than 1% which indicated the good precision of the method. 
2.4.2.3 Result of the recovery test 
As shown in Table 2.4, due to the lack of the herb, the recovery test for Tussilago 
farfara extract was just performed in duplicate. The results showed high accuracy 
(98.4%) of recovery test for senkirkine, which indicated a good accuracy of the 
method. 
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Table 2.4 Recovery of senkirkine in Tussilago farfara extract 
Senkirkine in Senkirkine Senkirkine a * 
Water Extract Spiked Determined (oZ。) (o/o) 
(昭) (M) (fig) - -
5.0 5.8 10.85 99.5 • 
5.0 ^ 1 1 ^ 973 • 
^Accuracy (%) = [1 - I Amount of senkirkine determined — (Amount of senkirkine in 
water extract + Amount of senkirkine spiked) I / (Amount of senkirkine in water 
extract + Amount of senkirkine spiked)] x 100 
2.4.2.4 Quantification of senkirkine in Tussilago farfara 
The developed H P L C - U V analytical method was subsequently applied to determine 
the PA component in the total alkaloids extract of Tussilago farfara. The quantity of 
PA component present in the extract is presented in Table 2.3. From the results, the 
amount of senkirkine was found to be very low in the Tussilago farfara crude water 
extract (0.12 mg/g extract). 
2.5 Qualitative and Quantitative Analysis of Gynura segetum 
2.5.1 Methods 
2.5.1.1 H P L C - U V condition 
The quantitative analysis of Gynura segetum was performed by H P L C with Agilent 
1100 system. A Jones A P E X O D S column (Waters 3 jim, 150 x 4.6 m m ) coupled 
with a guard column (Waters Spherisorb S5 0DS2, 10 x 4.6 m m ) was applied. The 
samples were analyzed at 25 with the flow rate of 0.8 ml/mm and U V detection at 
220 nm. The mobile phase of 0.03% diethylamine in distilled water : A C N (72 : 28, 
V : v) was employed. 
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2.5.1.2 H P L C - M S condition 
The mass spectrum was operated in a positive ion mode with an ESI interface. The 
temperature of nitrogen drying gas was 400 °C with the flow rate of 7 L/min. Ion 
spray voltage was 4000 V. The orifice and focusing ring voltage was 41 V and 210 V 
respectively for the in-source collision induced dissociation (CID) in both full scan 
and selected ion monitoring (SIM) conditions. In the full scan mode, the mass range 
was 50-800 (m/z). The chromatographic condition was the same as for H P L C - U V 
analysis. 
2.5.1.3 Calibration curves for senecionine and seneciphylline 
Two Methanol stock solutions containing senecionine and seneciphylline 
respectively were prepared and then diluted to appropriate concentration ranges for 
the construction of calibration curves. Each calibration curve was performed in 
triplicate with five different concentrations and the relative standard deviation (RSD) 
was taken as a measure of precision. Calibration curves were derived by plotting the 
concentrations of each standard compound as a function of peak area of spiked 
compound at the selected wavelength. 
2.5.1.4 Recovery test 
The recovery test was used to evaluate the accuracy of the method. Senecionine (42 
|ug) was added to the 15 m g of the water extract of Gynura segetum (containing 42 
)Lig of senkirkine) prior to HPLC-UV analysis. The resultant samples were then 
extracted and analyzed as described in Section 2.5.1.5. The mean recovery was 
calculated based on five assays and the relative standard deviation (RSD) was taken 
as a measure of precision. 
2.5.1.5 Sample test 
For the qualitative analysis with HPLC-MS system, the lyophilized powder of crude 
herbal extract (30 mg) was dissolved in 1 ml distilled water and filtered with a 0.45 
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jum PTFE membrane filter prior to H P L C - M S analysis. For the total alkaloid extract, 
1.2 m g of alkaloid extract was dissolved in 1.2 ml of methanol and filtered with a 
0.45|Lim PTFE membrane filter prior to the H P L C - M S analysis. Each sample was 
analyzed in triplicate. 
For the quantitative analysis with H P L C - U V system, the sample preparation was the 
same as the qualitative analysis described above. Each sample was analyzed in 
triplicate. 
2.5.2 Results and Discussions 
2.5.2.1 Qualitative analysis of PAs in Gynura segetum 
Authentic compounds of senecionine and seneciphylline were analyzed by 
H P L C - U V and H P L C - M S to provide the retention time (IR), U V , and mass 
spectrometry data for the comparison with those of compounds present in Gynura 
segetum extract respectively. The representative H P L C - U V chromatograms at 220 
n m and the mass spectra of the authentic compounds are shown in Figure 2.7 and 
Figure 2.8. 
As shown in Figure 2.7 (A), senecionine (IR 14.8 min) was eluted as a sharp and 
symmetric peak under the optimized chromatographic condition. The mass spectrum 
(Figure 2.8 (A)) exhibited an ion with the highest mass unit at m/z 336 corresponding 
to the protonated molecular ion [M+H] + of senecionine and two specific fragment 
ions for retronecine -type PAs (at 120 and 138 m/z). These characteristic fragment 
ions are in good agreement with the previously results (Lin et al., 1998). Furthermore, 
seneciphylline (IR 8.6 min), as shown in Figure 2.7 (B) and Figure 2.8 (B), was also 
determined similarly. 
Figure 2.7 (C) and Figure 2.8 (C and D) showed the representative HPLC-UV 
chromatogram (220 nm) and mass spectra of PAs in Gynura segetum crude extract 
respectively. With comparison of the ta and U V chromatogram of the authentic 
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compounds, peak 1 was preliminary identified to be seneciphylline and peak 2 was 
senecionine。Furthermore, peak 1 and peak 2 was unambiguously identified to be 
seneciphylline and senecionine respectively by H P L C - M S analysis. Thus, Gynura 
segetum was confirmed to contain two retronecine -type toxic PAs. The structures of 
these PAs and their characteristic fragment ions are shown in Figure 2.3 and Figure 
2.4. 
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Figure 2.7. H P L C - U V chromatograms at 220 nm. Representative HPLC-UV 
chromatogram of senecionine (A), seneciphylline (B) and the representative 
chromatogram of Gynura segetum extract (C). 
1： seneciphylline; 2: senecionine. 
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Figure 2.8. The representative mass spectrum of the authentic compound of 
senecionine (A), the authentic compound of seneciphylline (B), senecionine in 
Gynura segetum extract (C) and seneciphylline in Gynura segetum extract (D) 
obtained by H P L C - M S analysis. 
2.5.2.2 Calibration curves for senecionine and seneciphylline 
As shown in Table 2.1, both of the calibration curves for senecionine and 
seneciphylline showed good linearity (r^  > 0.999) in the concentration ranges 
tested. The R S D value for each concentration was lower than 5%, indicating the 
good precision of the method. 
2.5.2.3 Result of the recovery test 
As shown in Table 2.5, the obtained accuracy varied between 98.4% and 100.0% 
indicated a good accuracy of the method. R S D of 1.9% proved a good precision of 
the recovery test. Due to the limited amount of the authentic seneciphylline, the 
recovery test was conducted for senecionine. 
Table 2.5 Recovery of senecionine in Gynura segetum extract 
Senecionine Senecionine Senecionine . a a/t , … t^  …b 
。、飞了 。-1 J t a , 。 J Accuracy Mean 士 SD R S D 
in Water Spiked Determined 〕 ,o/、 
Extract (股） （即） （收） ⑷ （/。） （/o) 
42.0 42.0 84.0 100.0 
45.1 42.0 86.4 98.4 
42.2 42.0 84.8 99.1 99.3 士 1.9 1.9 
42.6 42.0 84.9 99.7 
43.9 99^ 
^Accuracy (%) 二 [1 - I Amount of senecionine determined - (Amount of senecionine 
in water extract + Amount of senecionine spiked) I / (Amount of senecionine in 
water extract + Amount of senecionine spiked)] xiOO 
bRSD (%) 二 (SD/mean) xlOO 
2.5.2.4 Quantification of PAs in Gynura segetum 
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The developed H P L C - U V analytical method was subsequently applied to determine 
PAs both in the crude herbal extract and the total alkaloids extract of Gynura segetum. 
The quantity of each PA component present in these extracts was summarized in 
Table 2.3. In both extracts, quantities of both PAs were high and the amount of 
seneciphylline was found to be twice of the amount of senecionine. Thus, the 
hepatotoxicity induced by Gynura segetum might be contributed by both 
seneciphylline and senecionine. Moreover, The content of PAs present in the total 
alkaloids extract (570 mg/g extract and 298 mg/g extract for seneciphylline and 
senecionine respectively) was significantly higher than that of the crude herbal 
extract (5.94 mg/g extract and 2.79 mg/g extract for seneciphylline and senecionine 
respectively). 
2.6 Qualitative and Quantitative Analysis of Crotalaria sessiliflora 
2.6.1 Methods 
2.6.1.1 H P L C - U V condition 
H P L C analysis was carried on H P 1100 system equipped with a Jones A P E X O D S 
column (Waters 3 |Lim, 150 x 4.6 m m ) coupled with a guard column (Waters 
Spherisorb S5 0DS2, 10 x 4.6 mm). The analytes were monitored at 220 n m and the 
column temperature was maintained at 25 °C. The mobile phase consisted of 1% 
CH3COOH (A) and methanol (B) with gradient elution as follows: 0-20 min, 
95%-80% A; 20-30 min, 80%-20% A; 30-40 min, 20%-20% A. The flow rate 
maintained at 0.8 ml/min. 
2.6.1.2 HPLC-MS condition 
The mass spectrum was operated in a positive ion mode with an ESI interface. The 
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temperature of nitrogen drying gas was 400。。with the flow rate of 7 L/min. Ion 
spray voltage was 4000 V. The orifice and focusing ring voltage was 41 V and 130 V 
respectively for the in-source collision induced dissociation (CID) in both full scan 
and selected ion monitoring (SIM) conditions. In the full scan mode, the mass range 
was 50-800 (m/zj. The chromatographic condition was the same as for H P L C - U V 
analysis. 
2.6.1.3 Calibration curve 
Methanol stock solution containing monocrotaline was prepared and diluted to five 
concentrations for calibration curve. Each concentration was performed in triplicate 
and the relative standard deviation (RSD) was taken as a measure of precision. 
Calibration curve was constructed by plotting the concentration of monocrotaline as 
a function of peak area of spiked monocrotaline at the selected wavelength. 
2.6.1A Recovery test 
The recovery test was used to evaluate the accuracy of the method. Monocrotaline 
(205 |Lig) was added to 1 m g water extracts of Crotalaria sessiliflora (containing 205 
monocrotaline) prior to the H P L C - U V analysis. The resultant samples were then 
extracted and analyzed as described in Section 2.6.1.5. The mean recovery was 
calculated based on five assays and the relative standard deviation (RSD) was taken 
as a measure of precision. 
2.6.1.5 Sample test 
For the qualitative analysis with HPLC-MS system, the lyophilized powder of crude 
herbal extract (2 mg) was dissolved in 1 ml distilled water and filtered with a 0.45 
|im PTFE membrane filter prior to HPLC-MS analysis. Each sample was analyzed in 
triplicate. 
For the quantitative analysis with HPLC-UV system, the sample preparation was the 
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same as the qualitative analysis described above. Each sample was analyzed in 
triplicate. 
2.6.2 Results and Discussions 
2.6.2.1 Qualitative analysis of monocrotaline in Crotalaria sessiliflora 
Authentic monocrotaline was analyzed by H P L C - U V and H P L C - M S to provide the 
retention time (Ir), UV, and mass spectrometry data for the comparison with those of 
compounds present in Crotalaria sessiliflora extract. The representative H P L C - U V 
chromatogram at 220 n m and the mass spectrum of monocrotaline are shown in 
Figure 2.9 (A) and Figure 2.10 (A). 
As shown in Figure 2.9 (A), monocrotaline (IR 16.1 min) was eluted as well-defined 
peak under the optimized chromatographic condition. The mass spectrum (Figure 
2.10 (A)) exhibited an ion with the highest mass unit at m/z 326 corresponding to the 
protonated molecular ion of monocrotaline and two specific fragment ions for 
retronecine -type PAs (at 120 and 138 m/z). 
Figure 2.9 (B) and Figure 2.10 (B) showed the representative HPLC-UV 
chromatogram (220 nm) and mass spectrum of monocrotaline in Crotalaria 
sessiliflora extract respectively. With comparison of the tR, U V chromatogram and 
mass spectrum of the authentic monocrotaline, the peak in Figure 2.9 (B) was 
unambiguously identified to be monocrotaline. The structure of monocrotaline and 
the characteristic fragment ions were shown in Figure 2.3 and Figure 2.4. 
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Figure 2.9. H P L C - U V chromatograms at 220 nm. Representative H P L C - U V 
chromatogram of monocrotaline (A) and the representative chromatogram of 
Crotalaria sessiliflora extract (B). 
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Figure 2.10. The representative mass spectrum of the authentic compound of 
monocrotaline (A) and monocrotaline in Crotalaria sessiliflora extract (B) obtained 
by H P L C - M S analysis. 
2.6.2.2 Calibration curve for monocrotaline 
As shown in Table 2.1, the calibration curve for monocrotaline showed good linearity 
(r2 = 0.9998) in the present concentration range. The R S D value for each 
concentration is lower than 2 % which indicated the good precision of the method. 
2.6.2.3 Result of the recovery test 
As shown in Table 2.6, the obtained accuracy varied between 93.6% and 97.0% 
indicated a good accuracy of the method. R S D of 0.5% proved a good precision of 
the recovery test. 
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Table 2.6 Recovery of monocrotaline in Crotalaria sessiliflora extract 
Monocrotaline Monocrotaline Monocrotaline Accurac ^ Mean± RSD^ 
in Water Spiked Determined qtT二、 fo/\ 
Extract (^g) _ _ ⑷ (/。） 
254.8 205 473.6 97.0 
214.9 205 436.7 96.0 
294.1 205 512.1 97.4 95.7 ±0.5 0.5 
260.3 205 491.7 94.3 
226.7 2 M 459.3 93^ 
^Accuracy (%) = [1 - I Amount of monocrotaline determined — (Amount of 
monocrotaline in water extract + Amount of monocrotaline spiked) I / (Amount of 
monocrotaline in water extract + Amount of monocrotaline spiked)] x 100 
bRSD (%) = (SD/mean) xlOO 
2.6.2.4 Quantification of PAs in Crotalaria sessiliflora 
The developed H P L C - U V analytical method was subsequently applied to determine 
the PA component in the crude herbal extract of Crotalaria sessiliflora. The quantity 
of PA component present in the extract was summarized in Table 2.3. Monocrotaline, 
a retronecine-type toxic PA, was determined in Crotalaria sessiliflora water extract 
with a high concentration (205 mg/g extract). 
2.7 Qualitative and Quantitative Analysis of Senecio scandens 
2.7.1 Methods 
2.7.1.1 H P L C - U V condition 
A Perkin Elmer series H P L C System was used. Chromatographic separation was 
achieved on an Agilent Extend-C18 column (4.6 x 250mm, 5 ^ m) connected with 
an Extend-C18 guard column (4.6 x 10 m m , 5 [xm). The column temperature was 
maintained 25 Mobile phase was composed of 0.03% aqueous diethylamine (A) 
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and acetonitrile (B) with gradient elution as follows: 0-40 min, 5%-45% B; 40-60 
min, 45%-90% B. The flow rate was 1 ml/min. 
2.7.1.2 H P L C - M S condition 
PE-SCIEX/Applied Biosystems API 365 LC-MS/MS system was used. The M S was 
operated in a positive ion mode with an ESI interface. The temperature of nitrogen 
drying gas was 400 °C with the flow rate of 7 L/min. Ion spray voltage was 4000 V. 
The orifice and focusing ring voltage was 41 V and 210 V respectively for the 
in-source collision induced dissociation (CID) in both full scan and selected ion 
monitoring (SIM) conditions. In the full scan mode, the mass range was 50-800 {m/z). 
In SIM mode, the individual intensity of six peaks was monitored for the 
characteristic ions at 120, 138, 150, 168, 122 and 140 m/z respectively. In M S / M S 
mode, the CID collision energy was 41 V. 
2.7.1.3 Sample test 
Lyophilized powder of Senecio scandens extract (2 mg) was dissolved in 1 ml 
distilled water and filtered with a 0.45 jum PTFE membrane filter prior to the 
HPLC/MS analysis. 
2.7.2 Results and Discussions 
2.7.2.1 Qualitative analysis of PAs in Senecio scandens 
Reference compounds of senecionine, seneciphylline and senkirkine were tested to 
optimize HPLC-MS conditions and also obtain the retention time (tR) and M S 
characteristics for the comparison。Under the present condition all PAs were eluted as 
sharp and symmetric peaks. As shown in Figure 2.11, the full scan M S spectra 
exhibited the corresponding protonated molecular ion [M+H]+ of each individual PA 
and two specific fragment ions for PAs in retronecine-type (at 120 and 138 m/z) and 
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otonecine-type (at 150 and 168 m/z), respectively. 
In the preliminary study, the total alkaloids extract of Senecio scandens was analyzed 
by H P L C - M S with flill scan mode, and only a few chromatographic peaks were 
observed in the total ion chromatogram (TIC), suggesting that the content of PAs in 
the sample might be very low. Therefore the extract was analyzed by HPLC-MS/MS 
to increase the detection sensitivity. As shown in Table 2.7, comparing with the data 
of the reference compounds, two retronecine-type PAs, senecionine and 
seneciphylline, and one otonecine-type PA, senkirkine, were found in the total 
alkaloids extract of Senecio scandens. 
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Figure 2.11 Mass spectra of the reference PAs. Senecionine (A); Seneciphylline (B); 
Senkirkine (C). 
58 
Table 2.7 Retention time, protonated molecular ion, characteristic fragmentation ions, 
and the proposed identity of PAs in the water extract of Senecio scandens analyzed 
by HPLC-MS/MS. 
tR (min) Protonated Characteristic Identity of PA 
molecular ion fragmentation ion {m/z) 
{m/z) 1 2 0 r ^ ” ” ” 1 6 8 
18.61 ^ - - + + Senkirkine 
27.52 334 + + - - Seneciphylline 
30.85 336 + + - - Senecionine 
2.7.2.2 Quantification of PAs in Senecio scandens 
From the total ion chromatograms of Senecio scandens extract, apparently 
seneciphylline was the major toxic PA, while other two PAs identified were only the 
minor ingredients in the herb. However, the content of total PAs was very low. In the 
present study, the content of toxic PAs in the extract was only semi-quantified due to 
the lack of the reference compounds. Since seneciphylline was found as the major 
toxic PA in the extract, the estimated amount of total toxic PAs in the herb was 
carried out based on the same way of quantification of seneciphylline. Briefly, 
content of seneciphylline was calculated through the calibration constructed from 
peak areas of accurately spiked seneciphylline analyzed by HPLC-MS, and contents 
of other two toxic PAs were also estimated similarly from seneciphylline calibration. 
The total content of the toxic PAs detected in Senecio scandens sample was 




Hepatotoxicity Induced by 
PA-containing Chinese Medicinal Herbs 
Although a large number of literatures on PAs which covers wide range from 
chemistry, pharmacology to toxicology have been published, the correlation between 
the amount of toxic metabolites (liver tissue-bound pyrroles) and the degree of 
hepatotoxicity induced by PA-containing Chinese medicinal herbs which are 
traditionally used in China and some other countries has not been well investigated. 
In order to study such correlation, five PA-containing Chinese medicinal herbs, 
namely Crotalaria sessiliflora, Gynura segetum, Ligularia hodgsonii, Tussilago 
farfara and Senecionis scandentis, were selected for the in vivo hepatotoxicity study 
in the present work. 
As described in Chapter 2, PAs and their contents in 5 different herbal water extracts 
were determined。 Retronecine-type PA-containing medicinal herbs include 
Crotalaria sessiliflora (205 mg/g monocrotaline in water extract) and Gynura 
segetum (2.79 mg/g senecionine and 5.94 mg/g seneciphylline in water extract). 
Otonecine-type PA-containing medicinal herbs include Ligularia hodgsonii (4.27 
mg/g clivorine and 0.11 mg/g ligularine in water extract) and Tussilago farfara (0.12 
mg/g senkirkine in water extract, see Table 2.3). Senecionis scandentis contained 
both types of PAs (0.03 mg/g toxic PAs together including senkirkine, seneciphylline 
and senecionine). In this chapter, the hepatotoxicity induced by these herbs and the 
formation of liver tissue-bound pyrroles were investigated in the male SD rats. 
In the present study, the degrees of hepatotoxicity induced in the male SD rats were 
evaluated by the biomarkers of hepatotoxicity as below. The general liver injury 
biomarkers, such as serum alanine aminotransferase (ALT) activity, hepatic levels of 
reduced form of glutathione (GSH) and apoptotic index of hepatocytes, were 
determined to examine the toxicity in the liver. Moreover, the characteristic hepatic 
morphological changes caused by PAs, including coagiilative necrosis and 
hemorrhage, and amount of liver tissue-bound pyrroles, a specific and unique 
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parameter only available with PA exposure, were also measured. In addition, in order 
to study the sub-acute toxicity effects, changes in liver to body ratio and liver weight, 
elevation of serum ALT activity, alteration of hepatic G S H level, and morphological 
changes of hepatocytes, were also assessed within 2 weeks after a single dose 
treatment of different PA-containing herbal extracts in rats. Finally, the data obtained 
from rats treated with different herbs were combined together to find out the 
correlation between the formation of liver tissue-bound pyrroles and the 
hepatotoxicity induced by PA-containing herbs. Moreover, liver tissue-bound 
pyrroles were determined to be a biomarker to predict the degree of hepatotoxicity 
induced by PA-containing medicinal herbs. 
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3.1 Materials and Methods 
3.1.1 Reagents 
The general reagents used in the present study and the corresponding supplying 
companies were listed as followed: 
Table 3.1 General reagents utilized in the hepatotoxicity study 
Reagent Supplying Company 
(For determination of serum ALT level) 
DL-alanine Sigma 
2,4-dimitrophenylhydrazine Sigma 
40% Hydrochloric acid BDH 
Sodium dihydrogenphosphate Merck 
Sodium Hydroxide BDH 
Sodium hydrogenphosphate Merck 
Sodium pyruvate Sigma 
(For determination of hepatic GSH level) 
5, 5'-dithiobis-2-nitrobenzoic acid Sigma 
Ethylediaminetetracetic acid (EDTA) Sigma 
Glutathione Sigma 
Potassium chloride Merck 
Potassium dihydrogenphosphate Merck 
Sodium bicarbonate Merck 
(For quantitation of the amount of liver tissue-bound pyrroles) 
Absolute Ethanol Pacreac Quimica SA 
Acetone (HPLC grade) LAS-Scan 
p-Dimethylaminobenzaldehyde Sigma 
Silver nitrate Sigma 
Trifluoroacetic acid Merck 
(For assessment of apoptotic index of hepatocytes) 
ApopTag S7100 (Apoptosis kit) Oncor 
Diaminobenzidine (DAB) Sigma 
H2O2 Riedel-de Haen 
(For observation of liver morphological changes) 
Eosin BDH 
40% Formalodehyde LAB-Scan 
Haematoxylin BDH 
Xylene LAB-Scan 
3.1.2 Animal Models 
Male Sprague Dawley rats (body weight, 190 — 220g) were supplied by the 
Laboratory Animal Services Centre at The Chinese University of Hong Kong. 
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Animals were placed in a controlled environment (50% relative humidity, 
temperature of 25°C and dark/light cycles) and allowed access to standard rat chow 
and water. 
For the study of acute hepatotoxicity, rats were randomly divided into various control 
and treatment groups (n = 5). Animals in treatment groups were gavaged with a 
single dose of each of herbal extracts while the ones in control groups were 
administered with vehicle (distilled water) correspondingly. After treatments, animals 
were placed in the controlled environment for one day. At 24 hours after 
administration, blood samples were collected by cardiac puncture after anesthetizing 
rats with diethyl ether, and liver samples were removed from the animals immediately 
after sacrifice by cervical dislocation. Liver samples were separated in several 
portions for glutathione determination, liver fixation (for assessments of 
morphological changes and hepatic apoptotic index), and liver tissue-bound pyrroles 
quantitation respectively. 
For the study of sub-acute hepatotoxicity, five groups of rats (n = 14) were gavaged 
with a single dose of Crotalaria sessiliflora herbal extracts on day 0 and the 
histological changes of livers were observed within 4 days. In detail, on day 1 (at 24 
hrs after administration), five animals in each group were sacrificed for the 
hepatotoxicity determination as described above. From day 2 to day 4, 3 animals 
from each treatment group were sacrificed in each day and the livers were collected 
for histology observation. All results were compared with those from the control 
group which conducted with distilled water in parallel. 
Moreover, seven groups of rats (n = 6) treated with Crotalaria sessiliflora herbal 
extracts were kept for 2 weeks to further observe the sub-acute hepatotoxicity. The 
rats were also orally treated with a single dose of water extract of Crotalaria 
sessiliflora on day 0 and weighted each day from day 0 to day 14. However, different 
numbers of rats in individual groups died due to the severe hepatotoxicity during the 
observation. The body and liver weights of dead rats were recorded and the post 
mortem liver specimens were collected for histology observation. On day 14, all the 
survival animals were sacrificed. The control group was treated with distilled water 
in parallel. 
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3.1.3 Determination of the Serum ALT Level 
The serum ALT level was determined with the sigma standard procedure (Sigma 
Diagnostics, manual No. 505) and the following solutions were prepared for the 
determination: 
1. Phosphate buffer solution (PBS): 420 ml 0.2 M sodium hydrogenphosphate and 80 
ml 0.1 M sodium dihydrogenphosphate were mixed together. pH of the mixture 
was adjusted to 7.4 by phosphoric acid; 
2. ALT substrate solution: the mixture of 0.2 M L-alanine and 1.8 m M a-ketoglutaric 
acid was prepared in PBS; 
3. D N P solution: 1 m M 2,4-dinitrophenylhydrazine (DNP) color reagent was 
prepared in 1 M hydrochloric acid solution; 
4. 0.4 M sodium hydroxide solution: 16 g sodium hydroxide powder was dissolved in 
1 L distilled water; 
5. Standard solution for calibration curve: 1.5 m M sodium pyruvate solution was 
prepared in PBS. 
All solutions were stored at 4。C for further use. 
The determination of serum ALT activity was based on the principle shown in 
Scheme 3.1. ALT catalized the transamination reaction of the substrates (L-alanine 
and a-ketoglutaric acid) to form the products (of-pyruvate and L-glutamate) under 
physiological conditions (pH7.4, 37°C). An end product of the transamination 
reaction, a-pyruvate, was reacted with 2,4-dinitrophenylhydrazine which also 
stopped the transamination reaction, to form the hydrazone complex 
(2,4-dinitrophenylhydrazone). This hydrazone complex was reacted with an alkaline 
diluent to form a colored complex which can be measured quantitatively in a 
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spectrophotometer. The calibration curve of ALT activity was carried out following 
the preparation summarized in Table 3.2. The five concentrations were conducted in 
triplicate. The upper limit of the determination was 125 SF unit/ml. 
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Scheme 3.1 The principle of determination of serum ALT activity. 
DNP: 2,4-dinitrophenylhydrazine 
66 
Table 3.2 Standard solutions for calibration curve of A L T determination and the 
corresponding A L T activity. 
Concentration of A L T Water Standard A L T Activity 
pyruvate Substrate (|li1) Pyruvate (SF Units/ml) 
(v/v a) (|Lll) Solution (iLll) 
0 m 0 0 
1/12 450 100 50 23 
1/6 400 100 100 50 
1/4 350 100 150 83 
1/3 300 100 200 125 
a v/v: volume of pyruvate solution / volume of standard solution. 
A L T substrate: L-alanine and a-ketoglutaric acid 
After preparation of the standard solutions in tubes, 0.5 ml D N P solution was added 
to each tube. The tubes were shaken and left at room temperature for 20 minutes. 
Then, 5 ml of 0.4 M sodium hydroxide solution was added to each tube and mixed 
by shaking。After at least 5 minutes, absorbency was read on a Pharmacia-LKB 4060 
UV-VIS spectrophotometer (Pharmacia) at 505 nm。Distilled water instead of 
calibration solutions was used as reference. The standard curve was obtained by 
plotting the absorbencies against the corresponding A L T activities as shown in Table 
3.2. 
The procedure for the determination of the serum ALT level of blood samples was as 
followed: 0.1 ml freshly collected serum was added to a test tube containing 0.5 ml 
ALT substrate solution and left in a water bath at 37°C for 30 minutes. Thereafter 0.5 
ml D N P solution was added to the tube. The tube was shaken and left at room 
temperature for 20 minutes. Finally, 5 ml of 0.4 M sodium hydroxide solution was 
added and the mixture was mixed by vortex. After at least 5 minutes, absorbency of 
the mixture was detected on a Pharmacia-LKB 4060 UV-VIS spectrophotometer at 
505 nm. The serum was replaced by distilled water and conducted as the above 
procedure to obtain the blank control for the detection reference. 
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3.1.4 Determination of Hepatic G S H Level 
The procedure for the determination of hepatic glutathione was conducted with a 
standard spectrophotometric method using Ellman's reagent (Akkerboon and Sies, 
1991). Firstly, the reagents were prepared as following: 
1. 24 m M potassium dihydrogenphosphate solution containing 0.1 m M EDTA; 
2. 0.5% sodium bicarbonate solution was prepared; 
3. 1.15% potassium chloride solution was prepared; 
4. 1.5 mg/ml D N T B solution was prepared by dissolving 
5,5'-dithiobis-2-nitrobenzoic acid (DNTB) m 0.5% sodium bicarbonate solution 
prepared above; 
5. 20 |liM GSH standard solution was prepared in 0.1 M phosphate buffer; 
6. Potassium dihydrogenphosphate/EDTA/Ethanol solution was prepared by adding 
the solution prepared in step 1 to absolute ethanol with volume ratio of 1:3 
(Solution prepared in step 1 : Absolute ethanol). 
The calibration curve of G S H was carried out with solutions described in Table 3.3 
by using the reagents mentioned above with denatured liver homogenate in triplicate. 
In detail, liver homogenates were prepared after transferred the rat liver portions in 
ice-cold 1.15% potassium chloride solution, dried blotted, weighted (1.0 g) and 
suspended in 9 ml of potassium dihydrogenphosphate/EDTA/Ethanoi solution, and 
homogenized at 4°C. The homogenates were centrifuged at 10,000 g for 15 minutes 
in a Sigma 2K15 laboratorium centrifuge with temperature control at 4 Clear 
supernatant was obtained. To denature the homogenate, supernatant was placed in 
oven at approximated 60-70°C for 12 hours. Finally, 30 denatured homogenate 
supernatant was added to each standard solution described in Table 3.3. The tubes 
were left to stand at room temperature for 10-15 minutes before reading the 
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absorbance on the Pharmacia-LKB 4060 UV-VIS spectrophotometer at 412 nm. The 
standard curve was derived by plotting the absorbency against the G S H 
concentration. For liver sample determination, 30 \il supernatant obtained from test 
sample was mixed with 150 \i\ D T N B and 2820 [x\ 0.1 M phosphate buffter. The 
mixture was left at room temperature for 15 minutes and then detected by 
spectrophotometer at 412 nm. 
Table 3.3 Standard solutions for calibration curve of G S H 
Tube 2 0 |liM D N T B 0.1 M Homogenate G S H 
Number G S H ()il) solution (|il) phosphate Supernatant concentration 
buffer (|il) (|Lil) (|Limol/g liver) 
1 0 ^ 0 
2 150 150 2670 30 1.0 
3 375 150 2445 30 2.5 
4 750 150 2070 30 5.0 
5 1125 150 1695 30 7.5 
6 1500 150 1320 30 10.0 
3.1.5 Quantitation of Liver Tissue-bound Pyrroles 
Amount of liver tissue-bound pyrroles was determined by using the Ehrlich reaction 
(Mattocks et al., 1970). The following reagents were used and needed to be daily 
freshly prepared: 
1. Ethanolic silver nitrate was prepared by dissolving 1 g silver nitrate in 50 ml 
absolute enthanol containing 5% trifluoroacetic acid; 
2. Ehrlich reagent was made by adding 1 g p-dimethylaminobenzaldehyde and 0.7 ml 
60% perchloric acid in 50 ml absolute ethanol. 
Liver portion (1 g) after dry blotted was homogenized in 10 ml acetone and 
centrifuged at 900 g for 5 minutes. The residue was washed with 10 ml ethanol and 
centrifuged for 5 minutes, and the resulted residue was reconstituted in 5 ml 
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ethanolic silver nitrate. The mixture was shaken for 30 minutes followed by 
centrifugation at 900 g for 5 minutes. The supernatant was collected. The residue was 
washed with 5 ml ethanol, centrifuged and supernatant was collected and combined 
with the supernatant obtained above. Ehrlich's reagent was added to the combined 
ethanolic extract with the ratio of 1:4 (v/v). The mixture was heated at 55�C for 10 
minutes. U V absorbance of the sample was measured at 562 and 625 n m on the 
Pharmacia-LKB 4060 UV-VIS spectrophotometer. Corrected absorbency (A) was 
determined by the following equation: A = 1.1(八562-八625). Bound pyrrolic metabolite 
levels were calculated using a molar absorptivity of the colored complex of 60,000 
(Mattocks and White, 1970). 
3.1.6 Histological Assessment of Liver Morphological Changes 
The upper left lobe of the liver obtained from the treated and control animals were 
rinsed in ice cold saline and fixed in a 10% phosphate buffered formaline for at least 
2 days。Thereafter, fixed liver portions were dehydrated by Pathcentre enclosed tissue 
processor (Shandono, England) following the process summarized in Table 3.4. 
Table 3.4 Dehydrating programme used in the present study 
S t ^ i 2 3 4 5 6 7 8 9 10 i T " 
Dehydrating ^ ^ ^ 1 0 0 % 1 0 0 % 1 0 0 % P ^ P ^ P a r a , 
solution EtOH EtOH EtOH EtOH EtOH EtOH 





After 22 hours dehydrating, tissues were embedded with wax and then trimed and 
sectioned on a J U N G RM2035 Microtome (Leica, Germany)。The thickness of each 
section was 5 ^im. Sections were then mounted on glass slides and dried at room 
temperature overnight. On the second day, sections were dewaxed and stained with 
Harris' haematoxylin and eosin by placing in solutions on the following order: 3 x 
]00% xylene, 100%, 95%, 80%, 70% ethanol for 5-10 minutes for each step to 
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dissolve the wax and hydrate the tissue for staining. Then the sections were rinsed 
with water and stained in haematoxylin solution for 5 minutes, rinsed with water 
again, put in acid ethanol for 2 minutes and washed with Scott's tap by quick shaking. 
Afterward stained with eosin for 3 minutes and then dehydrated again. The sections 
were observed under a Zeiss Axioplan2 microscope linked to a Spot RT-KE 2 M P 
Color Mosaic digital camera (Diagnostic Instruments, Sterling Heights, MI, U.S.A.). 
Evaluation of histological sections stained by hemotaxylin-eosin was performed. The 
following two histological changes were recorded: coagulative necrosis and 
hemorrhage. Each change was graded on a 4-point system as follows. Coagulative 
necrosis: -, absent; +, mild (centrilobular region involved without mid-lobular 
extension); ++, moderate (majority of lobules involved with mid-lobular extension); 
+++, severe (majority of lobules involved with mid-lobular extension in the majority). 
Hemorrhage: -, absent; +, mild (minority region around central vein involved); 
moderate (majority of central vein involved, with centnlobular extension); 丁+, 
severe (majority of the centrilobular region involved, with extension into the 
mid-lobular region). 
3.1.7 Assessment of Hepatocytes Apoptosis 
The apoptotic index of hepatocytes was determined with a commercial Apoptosis kit 
(ApopTag S7100, Oncor). Briefly, the dewaxed sections were incubated with 
Proteinase K and left at room temparture for 15 minutes, then sections were 
transferred to 0.3% H2O2 and stand for 15 minutes. Thereafter, sections were 
incubated with terminal deoxynucleotidyl transferase (TdT) in humidified chamber at 
37°C for 1 hr. Then Anti-Digoxigenin peroxidase conjugate and 0.05% D A B were 
added to sections in sequence. Finally, sections were counterstained with 
haematoxylin. The sections were observed under a Zeiss Axioplan2 microscope 
linked up with a Spot RT-KE 2MP Color Mosaic digital camera. The apoptotic index 
was calculated using the following equation: Apoptotic index = Number of apoptotic 
hepatocytes / Number of total hepatocytes x 100%. 
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3.1.8 Statistical Analysis 
All results were expressed as mean 士 standard deviation. One-way A N O V A (analysis 
of variance) and the post test of Dunnett's multiple comparison test were used for the 
comparison among more than two groups, while unpaired t-test was used for the 
comparison of two groups. The probability (p) less than 0.05 was considered 
statistically significant. 
3.2 Results and Discussion 
3.2.1 Calibration Curves 
3.2.1.1 Calibration curve for the determination of serum ALT activity 
Calibration curve is shown in Figure 3.1. Data were expressed in Sigma-Frankel Unit, 
which formed 4.82 x 10—4 jLimol Glutamate/minutes at pH 7.5 and The 
absorption was well correlated with the concentration of ALT in the present 
concentration range (r^  = 0.9928). The serum ALT activities of the treated rats were 
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0 25 50 75 100 125 150 
Activity of ALT (SF Unit/ml) 
Figure 3.1 Calibration curve for ALT determination 
Data were expressed as mean 士 SD (n = 3). 
3.2.1.2 Calibration curve of determination of hepatic G S H level 
Calibration curve for hepatic G S H level is shown in Figure 3.2. The correlation 
between absorption and glutathione concentration showed good linearity in the 
concentration range tested (r^  = 0.9913). The hepatic G S H levels of the treated rats 
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Figure 3.2 Calibration curve for determination of hepatic G S H level. 
Data were expressed as mean 土 SD (n = 3). 
3.2.2 Hepatotoxicity Study of Crotalaria sessiliflora 
3.2.2.1 Hepatotoxicity at 24 hrs after treatment 
Crotalaria sessiliflora is a monocrotaline-containing medicinal herb. In order to 
investigate the acute hepatotoxicity induced by Crotalaria sessiliflora, male SD rats 
were gavaged with a single dose of various dosages of water extract of Crotalaria 
sessiliflora respectively and the biological specimens were collected from rats at 24 
hrs after administration. 
3.2.2.1.1 Correlation between dosage of monocrotaline in Crotalaria sessiliflora 
water extract and amount of liver tissue-bound pyrroles 
Portions of liver samples were used for the quantification of the liver tissue-bound 
pyrroles using a well-established spectrophotometric method which has been 
described in 3.1.5. In the present study, liver tissue-bound pyrroles were successfully 
detected in all liver portions obtained from animals treated with the water extract of 
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Crotalaria sessiliflora. These results agreed with the identification and quanlification 
of this herb。As described in chapter 2, a toxic retronecine-type PA, monocrotaline, 
was determined in the water extract of Crotalaria sessiliflora with a high content of 
205 mg/g water extract. Thus the toxic metabolites - liver tissue-bound pyrroles 一 
should produce in body after the water extract ingestion. In order to investigate 
whether the hepatotoxicity induced by the Crotalaria sessiliflora extracts was 
uniquely produced by monocrotaline rather than other non-PA components present in 
the herb, two doses of pure monocrotaline were also selected to treat animals. As 
shown in Figure 3.3 and Table 3.5, the formation of the liver tissue-bound pyrroles 
increased dose-dependently. The correlation between dosage of monocrotaline 
present in Crotalaria sessiliflora water extract and amount of liver tissue-bound 
pyrroles showed a good linearity (r^  = 0.8154) and the pure monocrotaline also well 
fitted the linear correlation. 
8-1 
^ 7- o Monocrotaline 
T D ^ T 
§ 二 6- I ^ ^ 丄 X Crotalaria sessiliflora water 
5 T / ^ extract 
^ (f) 3' 
J 务 1- ^ 
oH 1 1 1 
0 1 2 3 
Dosage of Monocrotaline present in 
Crotalaria sessiliflora (mmol/kg) 
Figure 3.3 Correlation between dosage of monocrotaline and amount of bound 
pyrroles formed in the liver obtained from male SD rats orally dosed with 
monocrotaline or Crotalaria sessiliflora water extract, respectively. 
Dosage of monocrotaline used in the present study was calculated by the following 
equation: Dosage of monocrotaline (mmol/kg) = Dosage of water extract of 
Crotalaria sessiliflora (g/kg) x Content of monocrotaline in the extract (mg/g extract) 
/ Molecular weight of monocrotaline 
Data were expressed as mean 士 S E M (n = 5). 
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Table 3.5 Parameters measured in the acute hepatotoxicity study of Crotalaria 
sessiliflora 
Dosage of extract (g/kg) / Bound pyrrole A L T G S H 
Dosage of monocrotaline (jimol/g liver) (SF unit/ml) (|imol/g liver) 
(mmol/kg) 
0 50.19±2.21 4.253 ±0.23 
Ob 0 43.00 ±2.89 7.697 士 0.52 
Oc 0 40.87 士 1.28 5.30 土 0.31 
Od 0 48.98 ± 1.47 7.03 ±0.41 
0.31 /0.20 0.53 ±0.14 49.26 ± 3.47 6.84 ±0.51 
0.47/0.30 1.19 ± 0 . 0 6 57.44 ± 0.95 6.78 士 0.43 
0.50/ 0.32 0.52 ± 0.15 36.04 士 3.12 7.91 ±0.40 
0.60/0.38 1.08 士 0.17 57.04 土 4.51 10.37 士 0.42 
0.62 / 0.40 1.07 ± 0.13 57.75 土 6.26 6.05 ± 0.46 
0.78 /0.50 1.51 ± 0.13 56.64 ± 7.55 7.36 ±0.16 
0.80/0.51 1.35 士 0.14 58.64±8.52 11.14±0.19 
0.94/0.60 2.05 土 0.21 57.54 士 6.95 7.91 土 0.26 
1.00/0.64 1.66 ± 0.13 54.57 ± 6.05 8.85 ±0.89 
1.09 / 0 .70 2.35 ± 0.09 71.81 ± 5.35 7.73 ± 0.43 
1.20/0.77 2.16 士 0.06 75.63 ± 4 . 3 0 9.85 ± 0.34 
0 . 8 * 2 . 3 6 士 0 . 1 1 8 1 . 7 3 ± 1 1 . 0 4 7 . 5 2 士 0 . 5 9 
1 . 5 0 / 0 . 9 6 2 . 6 4 ± 0 . 1 9 8 8 . 5 9 士 1 3 . 6 9 8 . 6 6 ± 0 . 5 1 
2 . 0 / 1 . 2 8 2 . 8 1 ± 0 . 1 8 1 2 3 . 6 士 0 . 9 3 7 . 6 1 土 0 . 3 5 
1.7* 5.49 士 1.06 125.0 # 5.65 土 1.22 
4 . 0 / 2 . 5 6 6 . 6 6 士 0 . 8 7 1 2 5 . 0 # 7 . 4 4 士 1 . 7 4 
Oa： control of group A described in 3.2.2.1.2; Ob： control of group B described in 
3.2.2.1.2; Oc： control of group C described in 3.2.2.1.2; Od： control of group D 
described in 3.2.2.1.2; dosage of pure monocrotaline; : value higher than the 
upper limit of the serum ALT activity determination. 
Data were expressed as mean 士 S E M (n = 5). 
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As the mechanism of hepatotoxicity induced by PAs has been extensively 
investigated, it was confirmed that the liver tissue-bound pyrroles were directly 
related to PA-induced hepatotoxicity (Lin et aL, 2002). In the present study, the water 
extract of Crotalaria sessiliflora, a monocrotaline-containing herbal extract, was 
administered to animals to observe the formation of liver tissue-bound pyrroles. 
Results demonstrated that Crotalaria sessiliflora water extract which contained toxic 
PA monocrotaline produced liver tissue-bound pyrroles in rats. It indicated that the 
PA-containing medicinal herbs probably induce hepatotoxicity in vivo. 
In the present study, the amount of liver tissue-bound pyrroles was calculated based 
on the equation of Absorbance = 1.1 (abs562-abs625)/60 000. The quantitation method 
used in this study was based on the principle described by Mattocks A R . (Mattocks, 
et al., 1970). The pyrroles were released from liver tissues after treated with 
ethanolic silver nitrate and then reacted with Ehrlich reagent to generate a complex 
which has the strong absorbance at 562 n m (Scheme 3.2). However, the blood 
residue in the resultant solution also absorbed at 562 n m which may interfer with the 
pyrrole estimation. It was found that the blood absorbance at 562 and 625 nm were 
approximately equal. Thus, absorbance of blood residues at 562 n m can be 
substracted from the total absorbance at 562 n m by Absorbance562-Absorbance625-
However, this gave overcorrection because 10% of absorbance at 625 n m by pyrroles 
was substracted. Therefore, a correction factor 1.1 was employed and the correct 
pyrrole absorbance (abs) at 562 n m was given by: AbScorr =1.1 (abs562-abs625). 
Moreover, the molar absorptivity of the pyrrole-Ehrlich reagent complex was 
determined to be 60 000 (Mattocks and White, 1970). 
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3.2.2.1.2 Effects of Crotalaria sessiliflora on the serum A L T level 
The level of serum A L T activity reflects damage of hepatocytes and is considered to 
be a highly sensitive and fairly specific preclinical and clinical biomarker of 
hepatotoxicity (Ozer, et al., 2008) Therefore, in the present study, serum A L T activity 
was employed as the main biomarker to assess the degree of hepatotoxicity induced 
by PA-containing medicinal herbs. Since the basal serum A L T activity of the normal 
rats varied in a range of 20 to 50 SF unit/ml (Sigma Diagnostics, manual No. 505), 
the data obtained from four separately groups (Group A, B, C and D) conducted in 
separate days were separated in different figures and the statistical analysis was also 
conducted separately with the corresponding control (Figure 3.4 A-D). The results 
showed that Crotalaria sessiliflora water extract and pure monocrotaline were toxic 
to hepatocytes in a dose-dependent manner as indicated by increasing serum ALT 
activity measured at 24 hrs after administration. The dose of Crotalaria sessiliflora 
water extract of 0.47 g/kg, equal to 0.3 mmol/kg of monocrotaline, has already 
produced notable liver injury indicated by a significant elevation of serum ALT 
activities (p < 0.05, Figure 3.4 D). Moreover, when the dosage of Crotalaria 
sessiliflora water extract increased to 1.09 g/kg (monocrotaline, 0.7 mmol/kg), the 
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Figure 3.4 Effect of monocrotaline and monocrotaline-containing Crotalaria 
sessiliflora water extract on the serum ALT level in male SD rats orally dosed with 
monocrotaline or Crotalaria sessiliflora water extract respectively. 
Results were presented in four groups as shown in (A) — (D). 
Data were expressed as mean 士 S E M (n = 5). 
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A L T presents predominantly in cytoplasma and mitochondria of the liver, and also in 
skeletal muscle and heart tissue with much lower enzymatic activities (Tremlett and 
Oger, 2004). A L T plays an important role in amino acid metabolism and 
gluconeogenesis. It catalized the transamination reaction of L-alamine and 
a-ketoglutaric acid to form a-pymvate and L-glutamate (Scheme 3.1). Damaged 
hepatocytes which undergo necrosis lose plasma membrance integrity and release 
their contents such as A L T into the extracellular space. The released A L T ultimately 
enters into circulation and thereby the serum A L T activity increases compared to 
control subjects (Ozer et al., 2008). In the case of the PA-induced hepatotoxicity, it 
has been suggested that the damage of liver sinusoidal endothelial cells resulting in 
microcirculatory disturbances lead to hypoperfusion of the liver and the hepatocytes 
damage (Copple et al., 2002a). The coagulation system is also involved in the 
hepatocytes damage and promotes hepatocytes injury through deposition of insoluble 
fibin clots in the vasculature and induction of ischemia. Anticoagulants, such as 
heparin and warfarin, have been found decreasing monocrotaline-induced ALT 
release from hepatocytes in the male SD rats (Copple et al., 2002b). The present 
results proved that Crotalaria sessiliflora water extract indeed elevated the level of 
serum A L T activity. The results were consistent with the previous findings obtained 
with pure monocrotaline (Lin et al., 1998, Tang et al., 2007). Thus it could be 
concluded that Crotalaria sessiliflora can induce hepatotoxicity in male SD rats due 
to the presence of monocrotaline in the herb. The dose-dependent elevation of serum 
a l t level induced by Crotalaria sessiliflora water extract, as well as the 
dose-dependent formation of liver tissue-bound pyrroles which has been discussed in 
3.2.2.1.1, suggested that there may be a correlation between liver tissue-bound 
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Figure 3.5 Correlation between liver tissue-bound pyrroles and elevation of serum 
a l t activity in male SD rats orally dosed with Crotalaria sessiliflora water extract. 
(A) Mean plot of correlation between liver tissue-bound pyrroles and percentage of 
elevated ALT activity. (B) Mean plot of correlation between liver tissue-bound 
pyrroles and log value of percentage of elevated ALT activity. 
Mean of ALT % = E (ALT level of test - ALT level of individual control) / ALT 
level of individual control xlOO% / n 
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Mean of log A L T % = E log (ALT level of test - A L T level of individual control) / 
A L T level of individual control xlOO% / n 
Data were expressed as mean value (n = 5). 
In order to determine the correlation between the formation of liver tissue-bound 
pyrroles and the hepatotoxicity induced by Crotalaria sessiliflora, a mean plot of 
correlation between bound pyrroles and percentage of elevated A L T level was 
constructed (Figure 3.5 A). In Figure 3.5 A, an obvious correlation between two 
parameters was found (p< 0.001). Moreover, the semi-log profile plot provided a 
linear correlation between the liver tissue-bound pyrroles and percentage of elevated 
A L T level which yielded a simple linear equation of Y = 0.44X + 0.77 (r = 0.69,p< 
0.001, Figure 3.5 B). 
Although the mechanism by which PAs induced hepatotoxicity have been 
investigated for many years, no quantitation study has yet been conducted between 
the formation of liver tissue-bound pyrroles and the degree of hepatotoxicity induced 
by PA-containing medicinal herbs (or pure PAs). In the present study, a significant 
correlation between the amount of liver tissue-bound pyrroles and elevation of serum 
ALT level was found。Moreover, the positive slope of the straight line in Figure 3.5 B 
indicated a direct correlation between the two parameters and meant that the rate of 
elevation of serum A L T level increased while the liver tissue-bound pyrroles 
accumulated in body. These findings supported our hypothesis that the formation of 
liver tissue-bound pyrroles directly related to the degree of hepatotoxicity induced by 
PA-containing medicinal herbs and thus it has a potential to be developed as a 
biomarker to evaluate such liver injury. 
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3.2.2.1.3 The correlation between the elevated level of A L T activity and apoptosis of 
liver cells 
Previously, it has been proved that in most cases of acute liver injury (at 24 hrs after 
administration), hepatocytes are damaged and undergo both necrosis and apoptosis 
(Wallace et al., 2008). For example, carbon tetrachloride (CCI4), a well-known 
hepatotoxicant, was observed to induce cell death primarily via necrosis in mice, and 
a proportion of hepatocytes undergoing apoptosis have also been found (Bansal et al., 
2005). Thus, to further study the mechanism of hepatotoxicity induced by 
PA-containing medicinal herbs, in addition to the elevation of serum A L T activity 
which was mainly caused by necrosis progress, the apoptosis of hepatocytes was also 
determined at 24 hrs after dosing (Figure 3.6). As shown in Figure 3.7, the direct 
correlation indicated that the number of apoptotic cells in liver increased along with 
the elevation of serum A L T activity (r^  = 0.78, J9<0.001). Such mixed lesions had 
also been previously demonstrated in male S D rats dosed with monocrotaline 
(Copple et al., 2003). The results again indicated that the monocrotaline-containing 
medicinal herb, Crotalaria sessiliflora, induced hepatotoxicity in vivo due to the 
presence of monocrotaline in the herb. 
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Figure 3.6 Immunostaining of apoptotic hepatocytes on liver sections obtained from 
rats orally treated with a single dose of either (A) distilled water (vehicle control), or 
(B) water extract of Crotalaria sessiliflora (0.62 g/kg). 
Dots with reddish brown color: apoptotic cells. Bar represents 200 |im. 
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Figure 3.7 Correlation between percentage of elevated A L T level and percentage of 
apoptotic index of liver obtained from male SD rats dosed with individual herbal 
extract containing PA, respectively (n=13). 
Apoptotic index = Number of apoptotic hepatocytes / Number of total hepatocytes x 
100% 
3.2.2.1.4 Effects of Crotalaria sessiliflora on the hepatic G S H level 
Same as the determination of serum ALT activity, results of hepatic G S H quantitation 
were shown here in four seperate groups. The statistical analysis was conducted in 
each group seperately comparing with the individual control (Figure 3.8 A-D). When 
the dosage of water extract of Crotalaria sessiliflora was higher than 0.6 g/kg, equal 
to 0.38mmol/kg of monocrotaline, the hepatic G S H level of treated rats significantly 
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Figure 3.8 Effect of monocrotaline and monocrotaline-containing Crotalaria 
sessiliflora water extract on the hepatic G S H level in male SD rats orally dosed with 
monocrotaline or Crotalaria sessiliflora water extract respectively. 
Results were presented in four groups as shown in (A) — (D). 
Data were expressed as mean 土 S E M (n = 5). 
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It has been well established that hepatic glutathione (GSH) reacted with the toxic 
metabolites of PAs, to form non-toxic pyrrole-GSH conjugates which were easily 
excreted through urine. Exposure to PAs stimulated the G S H synthesis and thereby 
the hepatic G S H level increased. This increase was considered to represent a 
self-defense mechanism in preventing hepatotoxicity (Lin et al., 1999). However, the 
G S H depletion would be induced if too much toxic metabolites formed very rapidly 
and the self-defense system was overwhelmed (Yan and Huxtable, 1995). Previously, 
in vivo data established that there was an increase in hepatic G S H level at 24 hrs after 
administration of monocrotaline (Yan and Huxtable, 1995; Yan and Huxtable, 1996). 
The present results are in good agreement with those previously published results 
(Yan and Huxtable, 1995; Lin et al., 1999). The increase of the hepatic G S H level 
observed in m y study suggested the doses of water extract were not high enough to 
cause G S H depletion. Since the aim of the present study was to find out the toxic 
dosage thresholds of PA-containing medicinal herbs, the higher doses of Crotalaria 
sessiliflora water extract which might induce G S H depletion was not investigated. 
3.2.2.1.5 Histological changes of liver sections 
Liver sections obtained from rats treated with Crotalaria sessiliflora water extract 
were examined using H & E staining (Figure 3.9). It is well established that PAs can 
induce H V O D (hepatic veno-occlusive disease) which is mainly characterized by 
hemorrhage, coagulative necrosis of hepatocytes and fibrosis (Brooks et al., 1970; 
Copple et al., 2004; Ho et al., 2008). Thus in this study, hemorrhage and coagulative 
necrosis were selected as parameters to evaluate the hepatotoxicity induced by 
Crotalaria sessiliflora. Fibrosis would not be discussed here because it mainly 
occured in chronic PAs exposure (Ho et al., 2008). As shown in Table 3.6, no lesions 
were observed in livers obtained from the control rats. Coagulative necrosis of 
hepatocytes was typical in liver sections and present before hemorrhage when the 
dosage of water extract of Crotalaria sessiliflora was higher than 0.47 g/kg. 
Hemorrhage occurred firstly in areas around central veins when the dosage of water 
extract of Crotalaria sessiliflora was higher than 0.78 g/kg. In addition, damage in 
CVECs (central vein endothelial cells) also occurred and frequently progressed to 
completely loss vascular intima. However, damage in CVECs is hard to be quantified 
and was not determined in the present study. All lesions were dramatically 
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aggravated when the dosage of water extract of Crotalaria sessiliflora increased. 
A B 
Figure 3.9 Hematoxylin-eosin-stained liver sections. Rats were treated with a single 
dose of either distilled water as vehicle control (A) or water extract of Crotalaria 
sessiliflora (2.0 g/kg) (B). 
Line arrows indicate coagulative necrosis. Arrowheads indicate hemorrhage. Bar 
represents 100 jam. 
9 0 
Table 3.6 Morphological changes of liver sections obtained from rats treated with 
Crotalaria sessiliflora water extract at 24 hrs after administration 
Dosage of water extract (g/kg) / . 
Hemorrhage Coagulative necrosis 
Dosage of monocrotaline (mmol/kg) 
0 - -
0.31/0.20 - -
0.47 /0.30 - + 
0.50/0.32 - + 
0.60 /0.38 - + 
0.62 /0.40 - + 
0.78 /0.50 + ++ 
0.80/0.51 + ++ 
0.94 /0.60 ++ +++ 
LOO /0.64 ++ +++ 
1.09/0.70 +++ +++ 
1.20/0.77 +++ +++ 
0.80* +++ +++ 
1.50 / 0 . 9 6 + + + + + + 
2.00 /1.28 +++ +++ 
1.70* +++ +++ 
Each parameter was graded on a 4-point system as follows. Coagulative necrosis: 
absent; +, mild (centrilobular region involved without mid-lobular extension); ++, 
moderate (majority of lobules involved with mid-lobular extension); +++, severe 
(majority of lobules involved with mid-lobular extension in a majority). Hemorrhage: 
-,absent; +, mild (minority region around central vein involved); ++, moderate 
(majority of central vein involved, with centrilobular extension); +++, severe 
(majority of the centrilobular region involved, with extension into the mid-lobular 
region). 
*: pure monocrotaline. 
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3.2.2.2 Hepatotoxicity within 4 days after Administration 
To further observe the progress of liver lesions, five groups of rats were orally 
administered with a single dose of water extract of Crotalaria sessiliflora 
respectively, and sacrificed 4 days after dosing. Results exhibited that the progress of 
hemorrhage and coagulative necrosis was in a dose- and time-dependent manner 
(Table 3.7). Starting from day 2, rats treated with dosages of 0.94 or 1.09 g/kg were 
very sick. Ascites as well as the swollen and darkened livers was detected after 
surgical removal. 
Table 3.7 Morphological changes of liver sections obtained from rats treated with 
Crotalaria sessiliflora water extract within 4 days after administration 
Morphological Dosage of Time (day) 
changes extract (g/kg) 1 2 3 4 
0 - -
0.47 - 一 
0.62 -
Hemorrhage 
0.78 — — —— — -
Q 9 4 — ^ 一 — ‘ — ^ — ‘ — " — -
1.09 个一 ——— ——— ——-
0 - - - -
0.47 — — — 一 
Coagulative 0.62 + ， 一― —— 
necrosis 0.78 — — 一― ——— 
0.94 ——+ ——一 ——— ―― 
0 ； ‘ • ； ‘ I ‘ ’ ‘ ‘ 
.Uy ^ " ‘ “ “ ‘^ “ “ 
Each parameter was graded on a 4-point system as follows. Coagulative necrosis: 
absent; t, mild (centnlobular region involved without mid-lobular extension); 一一， 
moderate (majority of lobules involved with mid-lobular extension); + 丄了, severe 
(majority of lobules involved with mid-lobular extension in a majority). Hemorrhage: 
absent;十，mild (minority region around central vein involved); moderate 
(majority of central vein involved, with centrilobular extension); severe 
(majority of the centrilobular region involved, with extension into the mid-lobular 
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region). 
3.2.2.3 Sub-acute hepatotoxicity within 14 days after Administration 
To investigate the sub-acute hepatotoxicity induced by Crotalaria sessiliflora in rats, 
a 14-day observation of rats gavaged with a single dose of Crotalaria sessiliflora 
water extract were conducted. The dosages used in the treatment ranging from 0.3 to 
1.2 g/kg (containing monocrotaline ranged from 0.2 to 0.8 mmol/kg correspondingly) 
were selected based on the results of acute toxicity study. In the 14-day period, 
changes of the body weight (Figure 3.10), liver to body weight ratios (Table 3.8), and 
the morphological changes of liver sections (Table 3.9) were determined. Moreover, 
the mortality of rats was detected in the dosage groups of 0.78, 0.94, 1.09 and 1.23 
g/kg (Table 3.8). As shown in Table 3.8, when the dosage of water extract was higher 
than 0.78 g/kg, a number of rats died within one week after administration. The 
mortality increased along with the dosage increasing. Ascites and the swollen and 
darkened livers were observed in all bodies. Hepatomegaly was confirmed as 
indicated by significant increase in the liver to body weight ratio. Severe hemorrhage 
and coagulative necrosis was observed in all post mortem liver specimens (Table 3.9). 
However, it is interesting to note that the rats could survival afterwards if they did 
not die within one week。Changes of the body weight of rats are shown in Figure 
3.10. The body weight of control rats was time-dependently increased. The dose of 
0.31 g/kg did not induce significant difference in the body weight comparing to the 
control. Body weights of rats treated with the dosage of 0.47 g/kg or 0.62 g/kg 
time-dependently increased, but significantly different from the control group. 
However, comparing with the control, when the dosage of water extract was higher 
than 0.78 g/kg, significant decrease in body weight of treated rats was observed 
starting from 24 hrs after administration. 
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Table 3.8 Mortality and liver to body weight ratio of the rats treated with a single 
dose of water extract of Crotalaria sessiliflora within 14 days after administration 
Dosage of Number of rats died Total number Liver to body 
water extract in individual day of died rats weight ratio 
(g/kg) Day 2 D a y 4 ~ D a y 5 D a y 6 (n = 6) (%) 
5 ^ ~ 『 
0.78 1 1 6.10 
0.94 1 2 3 7.71** 
1.09 1 4 1 6 8.66** 
1.23 1 2 2 5 7.74** 
Liver to body weight ratio 二 Liver weight / Body weight x 100% 
< 0.01 vs. control. 
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350-1 —e— Control 
- ^ 0 . 3 1 g/kg 
3 2 5 - -斗-0.47 g / k g 
0.62 g/kg 
3 0 0 - — 0.78 g/kg 
+ 0 94 g/kg 
--必--1.09 g/kg ^ ^ ^ J r ^ 
S 275- + 1.23 g/kg … 叶 
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Figure 3.10 Body weights of male SD rats gavaged with Crotalaria sessiliflora water 
extract within 14 days after administration. 
* p < 0.05 comparing with control curve; **;?<0.01 comparing with control curve. 
Data were expressed as mean 士 S.E.M. (n =5) 
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Table 3.9 Morphological changes of liver sections obtained from rats treated with a 
single dose of water extract of Crotalaria sessiliflora within 14 days after 
administration 
Dosage Time (day) 
(mmol/kg) 2 4 5 6 14 
0 1 / / / -
0.2 / I I I -
0.3 / I I I -
0.4 / I I I -
Hemorrhage 
0.5 / / + + / + 十 
0.6 / / +++ ++ ++ 
0.7 / +++ +++ +++ / 
0.8 +++ +++ +++ / +++ 
0 / / / / -
0.2 / I I I -
0.3 / I I I -
Coagulative 0.4 / I I I -
Necrosis 0.5 / / +++ / ++ 
0.6 / / +++ +++ +++ 
0.7 / +++ +++ +++ / 
0.8 +++ +++ +++ / +++ 
Each parameter was graded on a 4-point system as follows. Coagulative necrosis: 
absent; +’ mild (centrilobular region involved without mid-lobular extension); ++, 
moderate (majority of lobules involved with mid-lobular extension); +++, severe 
(majority of lobules involved with mid-lobular extension in a majority). Hemorrhage: 
-,absent; +, mild (minority region around central vein involved); ++, moderate 
(majority of central vein involved, with centrilobular extension); +++, severe 
(majority of the centrilobular region involved, with extension into the mid-lobular 
region). /: data not available. 
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Figure 3.11 Effect of Crotalaria sessiliflora on the serum ALT activity (A) and the 
hepatic G S H level (B) in male SD rats at 14 days after oral administration of a single 
dose of water extract of Crotalaria sessiliflora. 
Data were expressed as mean 土 S.E.M. (n =5) 
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Table 3.10 Hepatotoxicity induced by a single dose of Crotalaria sessiliflora water 
extract in male SD rats at 14 days after administration. 
Dosage of water extract A L T G S H Liver to body 
(g/kg) (SF unit/ml) (|imol/g liver) weight ratio (%) 
一 “ ~ 0 48.98 ± 1.47 7.03 ±0.41 4.59 ±0.14 
0.31 51.22 士 1.35 8.01 ±0.19 4.40 ±0.14 
0.47 73.05 士 1.06 7.42 ± 0.24 4.66 士 0.06 
0.62 67.08 士 15.95 8.07 ±0.51 4.43 士 0.08 
Data were expressed as mean+SEM (n = 5). 
At 14 days after administration, liver to body weight ratios and morphology changes 
were determined in all survival rats. The results showed that dosage of 0.78, 0.94, 
1.09 and 1.23 g/kg significantly increased liver to body weight ratio of the treated 
rats (Table 3.8), while dosages of 0.31, 0.47 and 0.62 g/kg did not significantly alter 
such ratio (Table 3.10). The marked hemorrhage and coagulative necrosis were 
observed when the dosage of water extract was higher than 0.78 g/kg. On the other 
hand, when the dosage is lower than 0.62 g/kg, no liver lesion was detected (Table 
3.9). These results indicated that when the dosage of water extract of Crotalaria 
sessiliflora was lower than 0.62 g/kg, no significant liver injury was induced within 
two weeks after administration. To further confirm these findings, serum ALT 
activity and hepatic G S H level were determined in 0.31, 0.47 and 0.62 g/kg dosage 
groups. As shown in Figure 3.11 and Table 3.10, no significant alteration of serum 
ALT activity and hepatic G S H level was detected in these groups comparing with the 
control. 
The results from the present study suggested that the extract of Crotalaria sessiliflora 
induced sub-acute hepatotoxicity in a dose- and time-dependent manner. Rats 
survived afterwards if they did not die within one week suggested that the 
hepatotoxicity induced by Crotalaria sessiliflora may revised in body. Most of the 
results obtained from this study were consistent with the previous findings (Deleve et 
al., 1999; Yan et al., 1995; Yan et al” 1996). However, there were two findings 
different from the published data. Firstly, it was reported that body weight of male 
SD rats increased after gavaged with monocrotaline due to the hepatomegaly and 
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fluid retention such as ascites (Deleve et al” 1999). But in the present study, body 
weight of treated rats remarkably decreased in the same dosage range of the previous 
publication. One of the main reasons for the body weight decrease possibly was the 
reduction of food-intake of rats after administration (by observation only, no 
measurement). This indicated that the digestion and absorption system of treated rats 
were damaged due to the liver injury. Secondly, the fibrin deposition was observed in 
liver sections with the treatment of monocrotaline (Copple et al., 2002), but in this 
study, no evidence of fibrosis was discovered. This difference may be due to the 
different detection methods employed in the experiments. The specific 
immunostaining of fibrin was used in the study conducted by Copple and others 
while H & E staining was applied in the present study. 
3.2.2.4 Conclusion in hepatotoxicity study of Crotalaria sessiliflora 
From the above results, it could be concluded that Crotalaria sessiliflora, a 
monocrotaline-containing Chinese medicinal herb, induced hepatotoxicity in male 
SD rats due to the presence of monocrotaline. The major PA, monocrotaline, in the 
herb IS the key ingredient responsible for the herb intoxication, and the potency of 
hepatotoxicity correlated well with the content of monocrotaline presented in the 
herb (Figure 3.3). Both of the formation of liver tissue-bound pyrroles and the degree 
of hepatotoxicity indicated by the elevated serum A L T activity, hepatic G S H level, 
apoptosis of hepatocytes and morphological changes, exhibited in a dose-dependent 
manner. A linear correlation was also found between the amount of liver tissue-bound 
pyrroles and the elevated serum ALT activity (Figure 3.5). Thus, it was highly 
considered that liver tissue-bound pyrroles could be developed as a biomarker to 
indicate the degree of hepatotoxictiy induced by PA-containing Chinese medicinal 
herbs. Based on the correlation between the amount of liver tissue-bound pyrroles 
and the dosage of Crotalaria sessiliflora water extract (Figure 3.3), the dosage at 
which would induce hepatotoxicity in vivo could be determined based on the 
determination of the liver tissue-bound pyrroles. After analyzing all results obtained 
from the treatment of Crotalaria sessiliflora water extract, four important dosages of 
water extract of Crotalaria sessiliflora were found as following evidences: 
Firstly, the dosage of the water extract of Crotalaria sessiliflora, at which all treated 
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animals died, was determined to be 1.1 g/kg (the dosage of monocrotaline is 0.7 
mmol/kg). The amount of liver tissue-bound pyrroles of 2.4 jumol/g liver was 
determined accordingly: 
Evidence 1. All treated rats died within one week after administration (Table 3.8). 
The post mortem liver specimen showed significant hemorrhage and necrosis (Table 
3.11). Hepatomegaly was also observed as indicated by significant increases in liver 
to body weight ratio (Table 3.8). 
Evidence 2. At 24 hrs after administration, both serum A L T activity and hepatic G S H 
level significantly increased and extensive liver hemorrhage as well as coagulative 
necrosis was observed (Figure 3.4 C, Figure 3.8 C and Table 3.6). 
Evidence 3. Comparing with the control group, significant decrease in body weight 
of all treated rats was observed starting from 24 hrs after administration (Figure 
3.10). 
Secondly, the dosage of Crotalaria sessiliflora water extract, at which half of treated 
animals died, was determined to be 0.9 g/kg (the dosage of monocrotaline is 0.6 
mmol/kg). The amount of liver tissue-bound pyrroles of 2.1 ^imol/g liver was 
determined accordingly (Table 3.5): 
Evidence 1. Half of the treated rats died within one week after administration (Table 
3.8). The post mortem liver specimen showed significant hemorrhage and necrosis 
(Table 3.9). Hepatomegaly was also observed as indicated by significant increases in 
liver to body weight ratio (Table 3.8). 
Evidence 2. At 24 hrs after administration, both serum ALT activity and hepatic G S H 
level significantly increased and extensive liver hemorrhage as well as coagulative 
necrosis was observed was observed (Figure 3.4 C, Figure 3.8 C and Table 3.6). 
Evidence 3. Comparing with the control group, significant decrease in body weight 
of all treated rats was observed starting from 24 hrs after administration (Figure 
3.10). 
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Thirdly, the acute toxic dose of Crotalaria sessiliflora water extract was determined 
to be 0.8 g/kg (the dosage of monocrotaline is 0.5 mmol/kg). The amount of liver 
tissue-bound pyrroles of 1.5 |imol/g liver was determined accordingly (Table 3.5): 
Evidence 1. One of the treated rats died within one week after administration (Table 
3.8). The post mortem liver specimen showed significant hemorrhage and necrosis 
(Table 3.9). N o significant increase in liver to body weight ratio was observed 
comparing with control, indicating no significant hepatomegaly (Table 3.8). 
Hemorrhage and coagulative necrosis were also observed in the liver sections 
obtained from survived rats 14 days after administration (Table 3.9). 
Evidence 2。At 24 hrs after administration, both serum A L T activity and hepatic G S H 
level significantly increased (Figure 3.4 C, Figure 3.8 C). Marked liver hemorrhage 
and coagulative necrosis of hepatocytes was observed (Table 3.6). 
Evidence 3. Comparing with the control group, significant decrease in body weight 
of all treated rats was observed starting from 24 hrs after administration (Figure 
3.10). 
Fourthly, threshold of the dose of Crotalaria sessiliflora water extract causing 
hepatotoxicity was determined as 0.5 g/kg (the dosage of monocrotaline is 0.3 
mmol/kg). The amount of liver tissue-bound pyrroles of 1.2 ^imol/g liver was 
determined accordingly (Table 3.5): 
Evidence 1. At 24 hrs after administration, the serum A L T activity significantly 
increased whereas the hepatic G S H level showed no significant difference comparing 
with control (Figure 3.4 D, Figure 3.8 D). Only mild necrosis of hepatocytes can be 
observed in liver sections (Table 3.6). 
Evidence 2. Although body weight of the treated rats did not decrease after 
administration, it was still significantly lower than the untreated rats (Figure 3.10). 
Evidence 3. At 14 days after administration, serum ALT activity, hepatic G S H level, 
101 
morphology of liver sections and the liver to body weight ratio were all not 
significantly altered (Table 3.9, Table 3.10 and Figure3.9). This indicated that at the 
dosage of 0.5 g/kg, the acute hepatotoxicity induced by Crotalaria sessiliflora water 
extract was mild and able to recover within 14 days. 
Therefore, the possible biomarker, liver tissue-bound pyrroles, could be quantified 
appropriately as 1.2, 1.5, 2.1 and 2.4 lumol/g liver to be related to the toxic dose 
threshold, acute hepatotoxic dose, half death-inducing dose, and lethal dose of 
PA-containing medicinal herbs respectively. 
3.2.3 Hepatotoxicity Study of Gynura segetum 
Gynura segetum contained toxic PAs: senecionine and seneciphylline。In order to 
investigate the acute hepatotoxicity induced by Gynura segetum, and further evaluate 
the possibility of establishment of liver tissue-bound pyrroles as a biomarker, male 
SD rats were gavaged with a single dose of various dosages of water extract of 
Gynura segetum and the biological specimens were collected from rats at 24 hrs after 
administration for the various assessments. 
3.2.3.1 Correlation between the dosage of PAs present in Gynura segetum and the 
amount of liver tissue-bound pyrroles 
Portions of liver samples were used for the quantification of the liver tissue-bound 
pyrroles using the spectrophotometric method described in 3.1.5. As shown in Figure 
3.12 and Table 3.11, similar to the water extract of Crotalaria sessiliflora, the present 
results showed that the liver tissue-bound pyrroles were produced by the treatment of 
Gynura segetum in male SD rats. Moreover, the formation of the liver tissue-bound 
pyrroles exhibited in a dose-dependent manner. The correlation between the dosage 
of PAs present in Gynura segetum and amount of liver tissue-bound pyrroles showed 
a good linearity (r^  = 0.8858). Two toxic retronecine-type PAs, senecionine as the 
minor and seneciphylline as the major one, were determined in the water extract of 
Gynura segetum with content of 2.79 mg/g and 5.94 mg/g respectively. Thus the 
hepatotoxicity induced by Gynura segetum should be the overall effect of two PAs. 
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The slope of the straight line showed in Figure 3.12 was determined to be 5.85, 
which was much higher than that of Crotalaria sessiliflora (slope = 2.67), indicating 
the formation rate of liver tissue-bound pyrroles of Gynura segetum was high than 
that of Crotalaria sessiliflora. The difference was probably due to the different PAs 
present in these herbs. 
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Figure 3.12 Correlation between dosage of PAs present in Gynura segetum and 
amount of bound pyrroles formed in the liver obtained from male SD rats orally 
dosed with Gynura segetum water extract. 
Dosage of PAs present in Gynura segetum was calculated by the following equation: 
Dosage of PAs (mmol/kg) = Dosage of water extract of Gynura segetum (g/kg) x 
Content of senecionine in the extract (mg/g extract) / Molecular weight of 
senecionine (g/mol) + Dosage of water extract of Gynura segetum (g/kg) x Content 
of seneciphylline in the extract (mg/g extract) / Molecular weight of seneciphylline 
Data were expressed as mean 士 S E M (n = 5). 
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Table 3.11 Parameters measured in the acute hepatotoxicity of Gynura segetum 
Dosage of water extract (g/kg) / Bound pyrrole ALT GSH 
Dosage of PAs (mmol/kg) (|imol/g liver) (SF unit/ml) (jumol/g liver) 
0 0 47.32 ± 1.96 4.15 ±0.23 
3 / 0.08 0.60 士 0.08 52.36 士 1.70 3.99 士 0.37 
6 / 0 . 1 6 1.30 土 0.17 55.67 士 3.28 5.66 士 0.30 
1 2 / 0 . 3 2 2.25 士 0.25 61.98 士 5.：36 6.75 土 0.74 
15 /0.39 2.47 士 0.07 68.29 土 7.68 10.19 士 0.36 
1 8 / 0 . 5 0 3.14 士 0.15 83.34 士 18.34 6.24 士 0.64 
Data were expressed as mean 士 S E M (n = 5). 
3.2.3.2 Effects of Gynura segetum on serum A L T activity, hepatic G S H level and 
morphological changes of liver 
The serum A L T activity and the hepatic G S H level were determined to evaluate the 
degree of hepatotoxicity induced by Gynura segetum. As shown in Figure 3.13 (A), 
water extract of Gynura segetum dose-dependently induced the elevation of serum 
ALT activity. However, within the present dosage range, only the highest dose of 
water extract which contained 0.5 mmol/kg of PAs induced significant increase in 
serum ALT activity. On the other hand, the hepatic G S H level also elevated by 
Gynura segetum water extract indicating that the dosage of water extract was not 
high enough to induce G S H depletion in vivo (Figure 3.13 B). Coagulative necrosis 
of hepatocytes and hemorrhage were observed in liver sections with H & E staining. 
As shown in Table 3.12, Coagulative necrosis occurred when the dosage of PAs 
present in water extract was higher than 0.16 mmol/kg. Moreover, when the dosage 
of PAs was higher than 0.32 mmol/kg, hemorrhage also occurred. These findings 
suggested that water extract of Gynura segetum induced hepatotoxicity in male SD 
rats at 24 hrs after administration. The degree of hepatotoxicity correlated with the 
dosage of water extract. 
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Figure 3.13 Effect of Gynura segetum on (A) serum A L T avtivity and (B) hepatic 
G S H level in male SD rats orally dosed with Gynura segetum water extract. 
Data were expressed as mean±SEM (n = 5). 
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Table 3.12 Morphology changes of liver sections obtained from rats treated with 
Gynura segetum water extract at 24 hrs after administration 
Dosage of water extract (g/kg) / . 
Hemorrhage Coagulative necrosis 
Dosage of PAs (mmol/kg) 
0 - -
3/0.08 - -
6 / 0 . 1 6 - + 
12/0.32 + + 
15/0.39 + + 
18/0.50 + ++ 
Each parameter was graded on a 4-point system as follows. Coagulative necrosis: 
absent; +, mild (centrilobular region involved without mid-lobular extension); ++, 
moderate (majority of lobules involved with mid-lobular extension); +++, severe 
(majority of lobules involved with mid-lobular extension in a majority). Hemorrhage: 
-,absent; +, mild (minority region around central vein involved); ++, moderate 
(majority of central vein involved, with centrilobular extension); +++, severe 
(majority of the centrilobular region involved, with extension into the mid-lobular 
region). 
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Figure 3.14 Correlation between liver tissue-bound pyrroles and elevation of serum 
ALT level in male SD rats orally dosed with Gynura segetum water extract. 
(A) Mean plot of correlation between liver tissue-bound pyrroles and percentage of 
elevated ALT level. (B) Mean plot of correlation between liver tissue-bound pyrroles 
and log value of percentage of elevated ALT level. 
Mean of ALT % 二 E (ALT level of test - ALT level of individual control) / ALT 
level of individual control xlOO% / n 
Mean of log ALT % = E log (ALT level of test - ALT level of individual control) 
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/ A L T level of individual control xlOO% / n 
Data were expressed as mean value (n = 5), 
To further confirm the correlation between the formation of liver tissue-bound 
pyrroles and the hepatotoxicity induced by PA-containing herbs established with 
Crotalaria sessiliflora in 3.2.2.1.2, mean plots of correlation between the amount of 
liver tissue-bound pyrroles and elevated serum A L T level was constructed with data 
obtained from Gynura segetum-ixt^iQd groups. The semi-log plot provided a good 
linearity between the liver tissue-bound pyrroles and percentage of elevated ALT 
level (r^  = 0.82,;?<0.05, Figure 3.14). The best fit linear equation was Y 二 0.42 X + 
0.58, which was very similar to the equation established with Crotalaria sessiliflora 
(Y = 0.44 X + 0.77). These results suggested that different PA-containing medicinal 
herbs produced same amount of liver tissue-bound pyrroles in vivo if they elevated 
serum A L T activity to the same level. This finding verified that liver tissue-bound 
pyrroles could be a biomarker to predict the degree of hepatotoxicity induced by 
different types of PA-containing Chinese medicinal herbs。 
3.2.4 Hepatotoxicity Study of Ligularia hodgsonii 
Ligularia hodgsonii contained otonecine-type PAs, clivorine and ligularine, with the 
content of 4.27 mg/g and 0.11 mg/g respectively in water extract. To investigate the 
acute hepatotoxicity induced by Ligularia hodgsonii, male SD rats were gavaged 
with a single dose of water extract of Ligularia hodgsonii and the biological 
specimens were collected from rats at 24 hrs after administration for the 
hepatotoxicity assessment. 
3.2.4.1 Correlation between the dosage of PAs present in Ligularia hodgsonii and the 
formation of liver tissue-bound pyrroles 
Liver portions obtained from rats were used for the quantification of the liver 
tissue-bound pyrroles with the spectrophotometric method described in 3.1.5. As 
shown in Figure 3.15 and Table 3.13, amount of the liver tissue-bound pyrroles 
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formed in the treated animals increased dose-dependently. The correlation between 
the dosage of total PAs present in Ligularia hodgsonii and amount of liver 
tissue-bound pyrroles showed a good linearity (r^  = 0.8776) with the slope of 3.6. 
Comparing slopes among Ligularia hodgsonii (slope = 3.6), Crotalaria sessiliflora 
(slope = 2.67) and Gynura segetum (slope = 5.85), it was found that different 
PA-containing medicinal herbs generated liver tissue-bound pyrroles with different 
formation rates. Moreover, the highest amount of liver tissue-bound pyrroles detected 
in Ligularia /zoJg^ onz/-treated groups was just 0.27 |Limol/g, which was significantly 
lower than those produced by Crotalaria sessiliflora and Gynura segetum. The most 
possible reason is that different PAs contained in different herbal extracts with 
different contents: Ligularia hodgsonii contained otonecine-type PAs (clivorine: 4.27 
mg/g; ligularine: 0.11 mg/g) while Crotalaria sessiliflora (monocrotaline: 205 mg/g) 
and Gynura segetum (senecionine: 2.79 mg/g; seneciphylline: 5.94 mg/g) contained 
retronectine-type PAs. However, similar to those observed in Crotalaria sessiliflora 
and Gynura segetum-ixQdiiQdi groups, results of the present study again proved that 
there was a direct correlation between the dosage of PAs present in herbs and the 
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Figure 3.15 Correlation between dosage of PAs present in Ligularia hodgsonii and 
amount of bound pyrroles formed in the liver obtained from male SD rats orally 
dosed with Ligularia hodgsonii water extract. 
Dosage of PAs present in Ligularia hodgsonii was calculated based on the following 
equation: Dosage of PAs (mmol/kg) = Dosage of water extract of Ligularia 
hodgsonii (g/kg) x Content of clivorine in the extract (mg/g extract) / Molecular 
weight of clivorine (g/mol) + Dosage of water extract of Ligularia hodgsonii (g/kg) 
X Content of ligularine in the extract (mg/g extract) / Molecular weight of ligularine 
Data were expressed as mean ± S E M (n = 5). 
Table 3.13 Parameters measured in the acute hepatotoxicity study of Ligularia 
hodgsonii 
Dosage of water extract (g/kg) / Bound pyrrole ALT GSH 
Dosage of PAs (mmol/kg) (nmol/g liver) (SF unit/ml) (^imol/g liver) 
0 0 51.21 士 1.53 4.02 ±0.21 
3 / 0 . 0 3 2 0 4 7 . 0 6 士 2 . 6 5 4 . 0 0 士 0 . 3 4 
6 /0.065 O.U 士 1.17 48.42 士 2.21 3.92 士 0.29 
1 0 / a i 0 8 0-27 ±0.91 44.35 士 0.73 3.61 土 0.37 
Data were expressed as mean土SEM (n = 5). 
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3.2.4.2 Effects of Ligularia hodgsonii on serum A L T activity and hepatic G S H level 
In the dosage range tested, as shown in Figure 3.16 and Table 3.13, water extract of 
Ligularia hodgsonii did not significantly induce hepatotoxicity in rats determined by 
the serum A L T activity and hepatic G S H level. The amount of liver tissue-bound 
pyrroles produced by the highest dosage of 10 g/kg was just 0.27 |Limol/g liver. It is 
much less than the amount of 1.2 jumol/g liver determined by the water extract of 
Crotalaria sessiliflora which was suggested as threshold causing hepatotoxicity. 
Thus it was not surprised that no liver injury was detected. Moreover, the dosages 
higher than 10 g/kg were also investigated and serious stomach hydropsy at these 
dosages was observed with disturbed intestinal absorption. Therefore, the higher 
dosages could not be investigated to evaluate the PA-causing hepatotoxicity, and the 
correlation between the amount of liver tissue-bound pyrroles and the hepatotoxicity 
induced by the water extract of Ligularia hodgsonii could not be further studied. 
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Figure 3.16 Effect of Ligularia hodgsonii on (A) serum A L T activity and (B) hepatic 
G S H level in male SD rats orally dosed with Ligularia hodgsonii water extract. 
Data were expressed as meardiSEM (n = 5). 
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3.2.5 Hepatotoxicity Study of Tussilago farfara 
Tussilago farfara was used for many diseases, such as chronic dry cough, pulmonary 
diseases, menses problems, open wounds and inflammation of the eyes (Uzun et al” 
2004). Such a wide clinical use brought high risk of intoxification of such herbs due 
to the presence of toxic PAs. As described in 2.4.2.4, senkirkine, an otonecine-type 
PA, is present in Tussilago farfara with an extremely low content (0.12 mg/g water 
extract). To determine whether Tussilago farfara with such a low PA content could 
induce acute hepatotoxicity in vivo, male S D rats were treated with lOg/kg (equal to 
0.003 mmol/kg of senkirkine) of water extract of Tussilago farfara. At 24 hrs after 
administration, the amount of liver tissue-bound pyrroles, the serum A L T level and 
the hepatic G S H level were measured. As shown in Figure 3.17 and Table 3.14, 
dosage of 10 g/kg did not induce significant hepatotoxicity in rats indicated by the 
serum A L T activity and hepatic G S H level. Moreover, no formation of liver 
tissue-bound pyrroles was detected at this dosage (Table 3.14). Dosage of 10 g/kg 
was the highest dose to be used due to the limitation of solubility and injection 
volume. Thus the ftirther study of the acute hepatotoxicity induced by Tussilago 
farfara was not conducted. 
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Figure 3.17 Effect of Tussilago farfara on the serum A L T activity and the hepatic 
G S H level in male SD rats orally treated with water extract of Tussilago farfara. 
Dosage of PAs present in Tussilago farfara was calculated by the following equation: 
Dosage of PAs (mmol/kg) = Dosage of water extract of Tussilago farfara (g/kg) x 
Content of senkirkine in the extract (mg/g extract) / Molecular weight of senkirkine 
Data were expressed as mean±SEM (n = 5). 
Table 3.14 Parameters measured in the acute hepatotoxicity of Tussilago farfara 
Dosage of water extract (g/kg) / Bound pyrrole ALT GSH 
Dosage of PAs (mmol/kg) (fimol/g liver) (SF unit/ml) (^imol/g liver) 
0 0 51.95 ± 1.55 4.19 ±0.26 
10/••OO；^ 0 48.26 ±2 .89 3.74 ±0.16 
Data were expressed as mean±SEM (n = 5). 
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3.2.6 Hepatotoxicity Study of PA-containing Medicinal Herbs 
After studied the hepatotoxicity induced by Crotalaria sessiliflora, Gynura segetum, 
Ligularia hodgsonii, and Tussilago farfara individually, it was found that both of the 
formation of liver tissue-bound pyrroles and the hepatotoxicity induced by 
PA-containing medicinal herbs exhibited a dose-dependent manner. The formation 
rate of liver tissue-bound pyrroles depends upon the type of PAs and their contents in 
the herbal extracts. Hepatotoxicity induced by Crotalaria sessiliflora and Gynura 
segetum herbal extracts was directly related to the formation of liver tissue-bound 
pyrroles. However, no significant elevation of serum A L T activity was observed in 
Ligularia hodgsonii and Tussilago farfara-ixQdXQd groups mainly due to the low 
contents of PAs in the extracts. Thus, the data obtained from the Crotalaria 
sessiliflora and Gynura segetum-XvQdiiQd. groups were combined together here to give 
an overall view of how liver tissue-bound pyrroles indicates the degree of 
hepatotoxicity induced by different PA-containing medicinal herbs. 
3.2.6.1 Correlation between formation of liver tissue-bound pyrroles and elevated 
serum A L T level 
With the combined data obtained from all PA-containing medicinal herbs, mean plots 
of correlation between the amount of liver tissue-bound pyrroles and elevated serum 
A L T activity were constructed (Figure 3.18). The plots showed that the amount of 
liver tissue-bound pyrroles correlated well with the elevation of serum A L T activity. 
The direct correlation between the liver tissue-bound pyrroles produced by 
PA-containing medicinal herbs and log value of percentage of elevated ALT level 
was established (Figure 3.18B). The best fit equation was Y = 0.42 X + 0.71 (r^  = 
0.73, ；?<0.001), which showed no significant difference from those obtained from 
two herbs (Y = 0.42X + 0.58 and Y = 0.44X + 0.77 for Gynura segetum and 
Crotalaria sessiliflora respectively). These results supported that regardless of which 
type of PAs in the herb, the formation of liver tissue-bound pyrroles was directly 
related to the hepatotoxicity induced by the PA-containing herbs. The liver 
tissue-bound pyrroles could be a biomarker to predict the degree of hepatotoxicity 
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induced by different types of PAs and PA-containing Chinese medicinal herbs 
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Figure 3.18 Correlation between liver tissue-bound pyrroles and elevation of serum 
ALT level in male SD rats orally dosed with water extracts of PA-containing 
medicinal herbs. 
(A) Mean plot of correlation between liver tissue-bound pyrroles and percentage of 
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elevated A L T level. (B) Mean plot of correlation between liver tissue-bound pyrroles 
and log value of percentage of elevated A L T level. 
Data were expressed as mean value (n = 5). 
3.2.6.2 Correlation between dosage of PAs and amount of liver tissue-bound pyrroles 
As shown in Figure 3.19, the good linear regressions of Y = 5.85X + 0.26 and Y = 
2.67X + 0.08 were obtained for Gynura segetum and Crotalaria sessiliflora 
respectively with different slopes. The results indicated that at the same dosage of 
PAs present in herb, Gynura segetum produced higher quantity of liver tissue-bound 
pyrroles than that produced by Crotalaria sessiliflora. Thus it could be concluded 
that different types of PAs had different formation rate of liver tissue-bound pyrroles, 
and thus may induce different degrees of hepatotoxicity. Moreover, different 
threshold doses at which hepatotoxicities were induced could be found in different 
PA-containing medicinal herbs。 
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Figure 3.19 Correlation between dosage of PA and amount of bound pyrroles formed 
in the liver obtained from male SD rats orally dosed with monocrotaline or individual 
herbal extract containing PA, respectively. 
Data were expressed as meardiSEM (n — 5). 
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3.2.7 Test of Liver Tissue-bound Pyrroles as a Biomarker Using Senecionis 
scandentis 
This part of the study focused on testing the validity of liver tissue-bound pyrroles as 
a biomarker to predict the degree of hepatotoxicity induced by PA-containing 
medicinal herbs. Senecionis scandentis was selected to be studied because it is a 
common Chinese medicinal herb documented in China Pharmacopoeia for treating 
bacterial diarrhea, enteritis, conjunctivitis and respiratory tract infections. Its 
proprietary products are registered as over-the-counter remedies in China (Li et al., 
2008). Howerver, in Chapter 2, it had been found that one otonecine-type PA, 
senkirkine, and two retronecine-type PAs, seneciphylline and senecionine, were 
determined in Senecionis scandentis. The hepatotoxicity study was conducted at 24 
hrs after administration of herbal extract. As shown in Figure 3.20 and Table 3.15, 
dosage of 6 g/kg did not induce significant hepatotoxicity in rats indicated by the 
serum A L T activity and hepatic G S H level. N o formation of liver tissue-bound 
pyrroles was detected at this dosage (Table 3.15). Dose of 6 g/kg was the maximum 
dose due to the limitations of solubility and injection volume, and was the dosage 
equivalent to more than 10 times of the human daily intake recommended by China 
Pharmacopoeia. Thus it could be concluded that probably due to the too low content 
of toxic PAs present in the herb (6.95 \xglg herb), Senecionis scandentis could not 
induce acute hepatotoxicity in vivo. N o formation of the liver tissue-bound pyrroles 
consistents with the findings of no hepatotoxicity observed. Obviously, further 
confirmation of the potential biomarker of liver tissue-bound pyrroles with more 
PA-containing medicinal herbs is required. Due to the limitation of time, such 
confirmation will be conducted in future. 
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Figure 3.20 Effect of Senecionis scandentis on the serum A L T activity and the 
hepatic G S H level in male SD rats orally treated with water extract of Senecionis 
scandentis. 
Dosage of PAs present in Senecionis scandentis was estimated by the following 
equation: Dosage of PAs (mmol/kg) = Dosage of water extract of Senecionis 
scandentis (g/kg) x Content of toxic PAs in the extract (mg/g extract) / Mean of 
Molecular weight of the three toxic PAs 
Data were expressed as mean土SEM (n = 5). 
Table 3.15 Parameters measured in the acute hepatotoxicity of Senecionis scandentis 
Dosage of water extract (g/kg) / Bound pyrrole ALT GSH 
Dosage of PAs (mmol/kg) (^imol/g liver) (SF unit/ml) (jumol/g liver) 
0 0 40.86 ± 0.07 5.91 ± 0 . 1 3 
議 0 6 0 38.81 ± 0 . 0 4 6.42 ± 0.09 
Data were expressed as mean±SEM (n = 5)。 
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3.2.8 Conclusions 
From the above results, it could be suggested that regardless of types of PAs present 
in the herb, the formation of liver tissue-bound pyrroles directly correlated with the 
degree of hepatotoxicity induced by the PA-containing herbs (Figure 3.18). Moreover, 
the dosage threshold at which hepatotoxicity would be induced could be determined 
based on the amount of liver tissue-bound pyrroles (Figure 3.19). Liver tissue-bound 
pyrroles, would be a specific biomarker to predict the degree of hepatotoxicity 
induced by PA or PA-containing Chinese medicinal herbs. 
The amounts of liver tissue-bound pyrroles, which indicated the four important 
dosages of Crotalaria sessiliflora water extract described m 3.2.2.4, could also be 
employed to estimate the toxic dosages of other PA-containmg medicinal herbs. W e 
recommended that the amount of liver tissue-bound pyrroles of 1.2 ^mol/g liver 
indicated the threshold dose at which hepatotoxicity might be induced by 
PA-containing medicinal herbs, while the amount of liver tissue-bound pyrroles of 
1.5 |imol/g liver correlated with the acute toxic dose of PA-containing medicinal 
herbs. For instance, in case of Gynura segetum, the dose threshold can be found from 
Figure 3.19 to be about 0.16 mmol/kg of PA present m the extract and 7.0 mg/kg 
water extract based on 1.2 jumol/g of liver tissue-bound pyrroles. The acut toxic dose 
can be determined to be about 0.21 mmol/kg of PA present in the extract and 7.5 
mg/kg of the water extract indicated by 1.5 jumol/g of liver tissue-bound pyrroles. 
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Chapter 4 General Conclusions 
4.1 Qualitative and Quantitative Analysis of Five PA-containing Medicinal Herbs 
Five PA-containing medicinal herbs, namely Crotalaria sessiliflora, Gynura segetum, 
Ligularia hodgsonii, Tussilago far far a and Senecionis scandentis, were selected in 
the present study. Crotalaria sessiliflora and Senecionis scandentis have long been 
used in traditional Chinese medicine for anti-tumor and anti-inflammatory activities 
respectively while Ligularia hodgsonii and Tussilago far far a are used as antitussive 
agents (Hu et al., 1992; Ji et al., 2008; Koh et al., 2007; Liu et al., 2006). In addition, 
Gynura segetum is a folk medicinal herb for hemostasis and detumescence in 
northern China (Chen et al., 2007). All of the five herbs were widely used in China. 
PAs present in these herbs and their contents were determined by H P L C - M S and 
H P L C - U V analysis. As shown in Table 2.3, monocrotaline, a toxic retronecine-type 
PA, was detected in the crude water extract of Crotalaria sessiliflora with a high 
content of 205 mg/g extract。 Senecionine and senecipilline, two toxic 
retronecine-type PAs, were determined in Gynura segetum, with contents of 2.79 
mg/g of senecionine and 5.94 mg/g of senecipilline in the crude water extract, and 
relatively higher contents (298 mg/g and 570 mg/g for senecionine and senecipilline 
respectively) in the total alkaloids extract. Clivorine and ligularine, two toxic 
otonecine-type PAs, were identified in Ligularia hodgsonii. The contents of clivorine 
and ligularine in total alkaloid extract (564 mg/g and 15.6 mg/g for clivorine and 
ligularine respectively) were much higher than those in the crude water extract (4.27 
mg/g and 0.11 mg/g for clivorine and ligularine respectively). Moreover, in Tussilago 
farfara, an otonecine-type PA, senkirkine, was found with a low content of 0.12 
mg/g in the water extract. Finally, Senecionis scandentis was a special PA-containing 
medicinal herbs investigated in the present study, because it contained both 
otonecine- and retronecine -type PAs, senkirkine, senenciphylline and senecionine. 
However, the content of total toxic PAs in Senecionis scandentis was very low (6.95 
jug/g in dried herb and 0.03 mg/g in water extract)。 
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From the present results, it was demonstrated that different PA-containing medicinal 
herbs contained different types of PAs and their PA contents varied significantly 
(from 6.95 |Lig/g to 16.4 mg/g of dried herb). It is very likely that different 
PA-containing medicinal herbs may induce significantly different potencies of 
hepatotoxicity, and the regulations for the manufacture and clinical practice of such 
Chinese medicinal herbs to ensure safety were highly required. 
4.2 Hepatotoxicity Induced by PA-containing Medicinal Herbs in Rats 
As shown in Chapter 3, the water extract of Crotalaria sessiliflora dose-dependently 
induced significant acute (at 24 hrs after adminstraion) and sub-acute (within 14 days 
after administration) hepatotoxicity in the male SD rats, indicated by the elevation of 
serum A L T activity, hepatic G S H level, apoptotic index of hepatocytes, liver to body 
weight ratio, decrease of body weight, as well as histological changes of liver 
sections. The results from pure monocrotaline was consistent with those from 
Crotalaria sessiliflora water extract, indicating that Crotalaria sessiliflora induced 
hepatotoxicity was mainly due to the presence of monocrotaline, - a toxic 
retronecine-type PA. Gynura segetum was also observed to induce acute 
hepatotoxicity in rats in a dose-dependent manner. However, the other three 
PA-containing medicinal herbs, namely Ligularia hodgsonii, Tussilago farfara and 
Senecionis scandentis did not induce significant hepatotoxicity in the dosage ranges 
tested probably due to their very low content of toxic PAs. The differences in 
hepatotoxicity caused by different herbs were possibly due to different structures of 
PAs and their contents in different herbs. 
The hepatotoxicity induced by Crotalaria sessiliflora and Gynura segetum was 
dose-dependent. The different slopes (2.67 for Crotalaria sessiliflora and 5.85 for 
Gynura segetum) of the correlations between dosages of toxic PAs present in herbs 
and the amounts of liver tissue-bound pyrroles formed (Figure 3.19) suggested that at 
the same dosage of PAs present in herb, Gynura segetum generated a higher quantity 
of liver tissue-bound pyrroles than that produced by Crotalaria sessiliflora. The 
results demonstrated that different types of PAs exhibited different formation rates of 
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liver tissue-bound pyrroles, induced different degree of hepatotoxicity, and had 
different hepatotoxicity dose thresholds. Thus, for the safe use of PA-containing 
medicinal herbs, a unique biomarker, which can predict hepatotoxicity induced by 
different PA-containing medicinal herbs regardless of the type and content of PAs 
and estimate different toxic dose thresholds of different herbs is highly demanded. 
4.3 Correlation Between Hepatotoxicity Induced by PA-containing Medicinal Herbs 
and the Formation of Liver Tissue-bound Pyrroles 
Based on the data obtained from Crotalaria sessiliflora, Gynura segetum and 
Ligularia /zoJg^ o^ //-treated groups, the increases of amount of liver tissue-bound 
pyrroles and the degree of hepatotoxicity were both dose-dependent. Moreover, a 
good linearity of the correlation between amount of the liver tissue-bound pyrroles 
and the percentage elevation of A L T activities, as shown in Figure 3.18, 
demonstrated that regardless of types of PAs present in the herb, the formation of 
liver tissue-bound pyrroles directly correlated with the degree of hepatotoxicity 
induced by the PA-containing herbs. The more liver tissue-bound pyrroles produced, 
the more significant hepatotoxicity induced. Therefore, the liver tissue-bound 
pyrroles could be developed as a biomarker to predict the degree of hepatotoxicity 
induced by different types of PAs and PA-containing Chinese medicinal herbs 
4.4 Threshold of the Amount of Liver Tissue-bound Pyrroles Related to the 
Hepatotoxicity Induced by PA-containing Medicinal Herbs 
Based on the results obtained from Crotalaria sessiliflora-XTt?iXQd groups, four 
important amounts of liver tissue-bound pyrroles were determined with the evidences 
presented in 3.2.2.4. Firstly, 1.2 )Limol/g liver was estimated as a threshold amount of 
liver tissue-bound pyrroles, and a dose of any PA-containmg medicinal herb 
generating the liver tissue-bound pyrroles higher than such amount may have a high 
risk to cause acute liver injury. Secondly, amount of liver tissue-bound pyrroles of 
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1.5 |imol/g liver correlated with the acute toxic dose of PA-containing medicinal 
herbs. Thirdly, amount of liver tissue-bound pyrroles of 2.1 jumol/g liver was related 
to the dosage at which half of treated animals died. Finally, amount of liver 
tissue-bound pyrroles of 2.4 |Limol/g liver was related to the dosage at which all 
treated animals died. In case of Gynura segetum, the dose threshold was found from 
the correlation (Figure 3.19) as about 0.16 mmol/kg of PA present in the extract equal 
to 7.0 mg/kg of the water extract based on the calculation with the amount of liver 
tissue-bound pyrroles of 1.2 jumol/g liver. Similarly, the acute toxic dose was 
determined to be about 0.21 mmol/kg of PA present in the extract equal to 7.5 mg/kg 
of the water extract. 
Based on all results obtained from the present study, the liver tissue-bound pyrroles 
is a good biochemical parameter directly correlated to PA intoxication, and it have a 
potential to be developed as a biomarker to assess the PA- and PA-containing 
medicinal herb-induced hepatotoxicity. 
124 
R E F E R E N C E S 
A K K E R B O O N , T.P.M. & SIES, H. (1991). Assay of glutathione, glutathione 
disulphide and glutathione mixed disulphides in biological samples. Meth Enzymol, 
77’ 373-382. 
A L L E N , J.R., C H E S N E Y , C.F. & FRAZEE, W.J. (1972). Modifications of 
pyrrolizidine alkaloid intoxication resulting from altered hepatic microsomal 
enzymes. Toxicol Appl Pharmacol, 23, 470-479. 
B A N S A L , M.B., K O V A L O V I C H , K., G U P T A , R., LI, W., A G A R W A L , A., 
RASBILL, B., A L V A R E Z , C.E., SAFADI, R., FIEL, M.L, F R I E D M A N , S.L. & 
T A U B , R.A. (2005). Interleukin-6 protects hepatocytes from CCU-mediated necrosis 
and apoptosis in mice by reducing M M P - 2 expression. J Hepatol, 42, 548-556. 
B R A S , G , JELIFFE, D.B. & STUART, K.L. (1954). Veno-occlusive disease of the 
liver with non-portal type of cirrhosis occurring in Jamaica. Arch Pathol, 57, 
285-300. 
BRINK, N.G. (1982). Smatic and teratogenic effects induced by heliotrine in 
Drosophila. Mutat Res, 104, 105-111. 
B R O O K S , S. E. H., MILLER, C. G , M C K E N Z I E , K., A U D R E T S C H , J. J. & B R A S , 
G (1970). Acute veno-occlusive disease of the liver. Arch Pathol 89, 507-520. 
B U H L E R , D.R. & KEDZIERSKI, B. (1986). Biological reactive intermediates of 
pyrrolizidine alkaloids. Adv Exp Med Biol, 197, 611-620. 
C A N D R I A N , U., L U T H Y , J. & SCHLATTER, C. (1985). In vivo covalent binding 
of retronecine-labelled [3H]seneciphylline and [3H]senecionine to D N A of rat liver, 
lung and kidney. Chem Biol Interact, 54, 57-69. 
125 
C A R B A L L O , M., M U D R Y , M.D., LARRIPA, LB. & VILLAMIL, E. (1992). 
Genotoxic action of an aqueous extract of Heliotropium curassavicum van 
argentinum. Mutat Res, 279, 245-253. 
C A S T A G N O L I , N.J., R I M O L D I , J .M. , B L O O M Q U I S T , J. & C A S T A G N O L I , K.P. 
(1997). Potential metabolic bioactivation pathways involving cyclic tertiary amines 
and azarenes. Chem Res Toxicol, 10, 924-940. 
C H E E K E , R.R (1994). A review of the functional and evolutionary roles of the liver 
in the detoxification of poisonous plants, with special reference to pyrrolizidine 
alkaloids. Vet Hum Toxicol, 36, 240-247. 
C H E N , M.Y., CAI, J.T. & D U , Q. (2007). Hepatic veno-occlusive disease associated 
with the use of Gynura segetum. Eur J Intern Med, 18, 609. 
C H O U , M.W., W A N G , Y.R, Y A N , J., Y A N G , Y.C., B E G E R , R.D., WILLIAMS, L.D., 
D O E R G E , D.R. & FU, P.P. (2003). Riddelliine N-oxide is a phytochemical and 
mammalian metabolite with genotoxic activity that is comparable to the parent 
pyrrolizidine alkaloid riddelliine. Toxicol Lett, 145, 239-247。 
C H U N G , W.G. & B U H L E R , D.R. (1995). Major factors for the susceptibility of 
guinea pig to the pyrrolizidine alkaloid jacobine. Drug Metah Dispos, 23, 1263-1267. 
COPPLE, B.L., B A N E S , A., G A N E Y , RE. & R O T H , R.A. (2002a). Endothelial cell 
injury and fibrin deposition in rat liver after monocrotaline exposure. Toxicol Sci, 65, 
309-318. 
COPPLE, B.L., RONDELLI, C.M., M A D D O X , J.F., H O G L E N , N.C., G A N E Y , RE. 
& R O T H , R.A. (2004). Modes of cell death in rat liver after monocrotaline exposure. 
Toxicol Sci, 77, 172-182. 
COPPLE, B.L., W O O L L E Y , B., B A N E S , A., G A N E Y , RE. & R O T H , R.A. (2002b). 
Anticoagulants prevent monocrotaline-induced hepatic parenchymal cell injury but 
not endothelial cell injury in the rat. Toxicol Appl Pharmacol, 180, 186-196。 
126 
CUI, Y. & LIN, G. (2000). Simultaneous analysis of clivorine and its four microsomal 
metabolites by high-performance liquid chromatography. J Chromatogr A, 903, 
85-92. 
C U L V E N O R , C.C. (1968). Tumor-inhibitory activity of pyrrolizidine alkaloids. J 
Pharm ScU 57, 1112-1117. 
C U L V E N O R , C.C.J. (1978). Pyrrolizidine alkaloids: occurrence and systematic 
importance in angiosperms. Bot Notiser, 131, 473-478. 
C U S H N Y , A.R. (1911). On the action of senecio alkaloids and the causation of the 
hepatic cirrhosis of cattle. J Pharmacol Exp Ther, 2, 531-548. 
DAI, M., Y U , Y.C., R E N , T.H., W U , J.G., JIANG, Y., SHEN, L.G. & Z H A N G , J. 
(2007). Gynura root induces hepatic veno-occlusive disease: a case report and review 
of the literature. World J Gastroenterol, 13, 1628-1631. 
D E L E V E , L.D., M C C U S K E Y , R.S., W A N G , X., H U , L., M C C U S K E Y , M.K., 
EPSTEIN, R.B. & K A N E L , G.C. (1999). Characterization of a reproducible rat 
model of hepatic veno-occlusive disease. Hepatology, 29, 1779-1791. 
D H A R M A N A N D A , S. (2001). Safety issue affecting herbs: pyrrolizidine alkaloids. 
http:// www, it man line, org/arts/pas. htm. 
D U E K E R , S.R., L A M E , M.W., JONES, A.D., M O R I N , D. & SEGALL, H.J. (1994). 
Glutathione conjugation with the pyrrolizidine alkaloid, jacobine. Biochem Biophys 
Res Commun, 198, 516-522. 
D U E K E R , S.R., L A M E , M.W., M O R I N , D., W I L S O N , D.W. & SEGALL, H.J. 
(1992). Guinea pig and rat hepatic microsomal metabolism of monocrotaline. Drug 
Metab Dispos, 20, 275-280. 
DWrVEEDI, Y., RASTOGI, R., S H A R M A , S.K., M E H R O T R A , R., G A R G , N.K.& 
127 
D H A W A N , B.N. (1991). Picroliv protects against monocrotaline-induced hepatic 
damage in rats. Pharmacol Res, 23, 399-407. 
E D G A R , J.A., LIN, H.J.., K U M A N A , C.R. & NG, M . M . (1992). Pyrrolizidine 
alkaloid composition of three Chinese medicinal herbs, Eupatorium cannabinum, E 
japonicum and Crotalaria assamica. Am J Chin Med, 20, 281-288. 
FU, P.P., XIA, Q., LIN, G & C H O U , M . W . (2004). Pyrrolizidine 
alkaloids-genotoxicity, metabolism enzymes, metabolic activation, and mechanisms. 
Drug Metab Rev, 36, 1-55. 
FU, P.P., Y A N G , Y., XIA, Q., C H O U , M.W., GUI, Y.Y & LIN, G (2002). 
Pyrrolizidine alkaloids-tumorigenic components in Chinese herbal medicines and 
dietary supplements. J Food Drug Anal, 4, 198-211. 
G L O W A Z , SI., MICHNIK, M . & H U X T A B L E , R.J. (1992). Detection of a reactive 
pyrrole in the hepatic metabolism of the pyrrolizidine alkaloid, monocrotaline. 
Toxicol Appl Pharmacol, 115, 168-173。 
H A R T M A N N , T. & WITTE, L. (1995). Chemistry, biology and chemoecology of 
the pyrrolizidine alkaloids. In: Pelletier S W (Ed.). Alkaloids-Chemical and 
biological perspectives, Pergamon Press, Oxford, 9, 155. 
HERRLIN, K., S E G E R D A H L , M., G U S T A F S S O N , L L . & K A L S O , E. (2000). 
Methadone, ciprofloxacin, and adverse drug reactions. Lancet, 356, 2069-2070. 
HINCKS, J.R., KIM, H.Y., SEGALL, H.J., M O L Y N E U X , R.J., STERMITZ, F.R. & 
C O U L O M B E , R.A.J. (1991). D N A cross-linking in mammalian cells by 
pyrrolizidine alkaloids: structure-activity relationships. Toxicol Appl Pharmacol 111, 
90-98. 
H I R O N O , 1. (1981). Natural carcinogenic products of plant origin. CRC Crit Rev 
Toxicol 11’ 235-277. 
128 
H O , V.T., R E V T A , C. & R I C H A R D S O N , RG. (2008). Hepatic veno-occlusive 
disease after hematopoietic stem cell transplantation: update on defibrotide and other 
current investigational therapies. Bone Marrow Transplant, 41, 229-237. 
H O S O K A W A , M., M A K I , T. & SATOH, T. (1990). Characterization of molecular 
species of liver microsomal carboxylesterases of several animal species and humans. 
Arch Biochem Biophys, 277, 219-227. 
H U , S., CAI, W., YE, J., QIAN, Z. & SUN, Z. (1992). Influence of medicinal herbs 
on phagocytosis by bovine neutrophils. Zentralbl Veterinarmed A, 39, 593-599. 
H U X T A B L E , RJ. (1989). Human health implication of pyrrolizidine alkaloids and 
herb containing them. Toxicants of Plant Origin., Vol I Alkaloids C R C Press, Inc, 
Florida. 
H U X T A B L E , R.J. & W I L D , S.L. (1994). Relationship between in vitro metabolism 
of pyrrolizidine alkaloids and extrahepatic toxicity in vivo. Proc West Pharmacol Soc, 
37, 109-111. 
I M A O K A , S.’ FUJITA, S., F U N A E , Y. (1991). Age-dependent expression of 
cytochrome P-450s in rat liver. Biochim Biophys Acta, 1097, 187-192. 
I N T E R N A T I N O N A L P R O G R A M M E O N C H E M I C A L S A F E T Y (1989). 
Pyrrolizidine alkaloids health and safety guide. Health and Safety Criteria Guide, 26, 
W H O : Geneva. 
J A K O B S S O N , P.J., M O R G E N S T E R N , R., MANCINI, J., F O R D - H U T C H I N S O N , A. 
& PERSSON, B. (2000). Membrane-associated proteins in eicosanoid and 
glutathione metabolism (MAPEG). A widespread protein superfamily. Am J Respir 
Crit Care Med, 161, S20-S24. 
JI，L.L., C H E N , Y. & W A N G , Z.T. (2008). The toxic effect of pyrrolizidine alkaloid 
clivorine on the human embryonic kidney 293 cells and its primary mechanism. Exp 
Toxicol Pathol 60, 87-93. 
129 
K A S A H A R A , Y., K I Y A R A K E , K., TATSUMI, K., SUGITO, K., K A K U S A K A , I., 
Y A M A G A T A , S., O H M O R I , S., KITADA, M . & K U R I Y A M A , T. (1997). 
Bioactivation of monocrotaline by P-450 3A in rat liver. J Cardiovasc Pharmacol, 30, 
124-129. 
K A V V A D I A S , D., A B O U - M A N D O U R , A.A., C Z Y G A N , F.C., B E C K M A N N , H., 
S A N D , P., RIEDERER, P. & SCHREIEU, P. (2000). Identification of 
benzodiazepines in Artemisia dracunculus and Solanum tuberosum rationalizing their 
endogenous formation in plant tissue. Biochem Biophys Res Commun, 269, 290-295. 
KIM, H.Y., STERMITZ, F.R. & C O U L O M B E , R.A.J. (1995). Pyrrolizidine 
alkaloid-induced DNA-protein cross-links. Carcinogenesis, 16, 2691-2697. 
KL人SEK, A., V R U B L O V S K Y , P. & SANTAVY，F. (1967). Isolation of pyrrolizidine 
alkaloids from the plant Senecio revularis D.C. and Ligularia clivorum Maxim. 
Collection Czechoslov Chem Commun, 32, 2514-1522。 
K O H , S.B., K A N G , M.H., KIM, T.S., PARK, H.W., P A R K , C.G., SEONG, Y.H. & 
SEONG, H.J. (2007). Endothelium-dependent vasodilatory and hypotensive effects of 
Crotalaria sessiliflora L. in rats. Biol Pharm Bull, 30, 48-53. 
LI, S.L., LIN, G , FU, P.P., C H A N , C.L., LI, M., JIANG, Z.H. & Z H A O , Z.Z. (2008). 
Identification of five hepatotoxic pyrrolizidine alkaloids in a commonly used 
traditional Chinese medicinal herb, Herba Senecionis scandentis (Qianliguang). 
Rapid Commun Mass Spectrom, 22，591-602. 
LIN, G , CUI, Y.Y. & H A W E S , E.M. (1998). Microsomal formation of a pyrrrolic 
alcohol glutathione conjugate of clivorine. Firm evidence for the formation of a 
pyrrolic metabolite of an otonecine-type pyrrolizidine alkaloid. Drug Metab Dispos, 
26, 181-184. 
LIN, G , CUI, Y.Y. & LIU, X.Q. (2003). Gender differences in microsomal metabolic 
activation of hepatotoxic clivorine in rat. Chem Res toxical, 16, 768-774. 
130 
LIN, G , GUI, Y.Y., LIU, X.Q., & W A N G , Z.T. (2002). Species differences in the in 
vitro metabolic activation of the hepatotoxic pyrrolizidine alkaloid clivorine. Chem 
Res Toxicol, 15,1421-1428. 
LIN, G. LIU, X.Q. & CUI, Y. (2001). Human CYP3A4 mediation of the formation of 
the hepatotoxic metabolites of clivorine (abstract). Drug Metab Rev, 33, 96. 
LIN, G , N N A N E , LP. & C H E N G , T.Y. (1999). The effects of pretreatment with 
glycyrrhizin and glycyrrhetinic acid on the retrorsion-induced hepatotoxicity in rats. 
Toxicon, 37, 1259-1270. 
LIN, G , ROSE, R, C H A T S O N , K.B., H A W E S , E.M., Z H A O , X.G. & W A N Q Z.T. 
(2000). Characterization of two structural forms of otonecine-type pyrrolizidine 
alkaloids from Ligularia hodgsonii by N M R spectroscopy. J Nat Prod, 63, 857-860. 
LIN, G , Z H O U , K.Y., Z H A O , X.G, W A N G , Z.T. & BUT, P.P. (1998). Determination 
of hepatotoxic pyrrolizidine alkaloids by on-line high performance liquid 
chromatography mass spectrometry with an electrospray interface。Rapid Commun 
Mass Spectrom, 12, 1445-1456. 
LIU, K.Y., Z H A N G , T.J., G A O , W.Y., C H E N , H.X. & Z H E N G , Y.N. (2006). 
Thytochemical and pharmacological research progress in Tussilago farfara:. 
Zhongguo Zhong Yao Za Zhi, 31, 1837-1841. 
M A T T O C K S , A.R. (1968). Toxicity of pyrrolizidine alkaloids. Nature, 217, 723-728. 
M A T T O C K S , A.R. (1972). Acute hepatotoxicity and pyrrolic metabolites in rats 
dosed with pyrrolizidine alkaloids. Chem Biol Interact, 5, 227-242. 
M A T T O C K S , A.R. (1986). Chemistry and toxicology of pyrrolizidine alkaloids, 
Academic Press: London, NY. 
M A T T O C K S , A.R & BIRD, 1. (1983). Alkylation by dehydroretronecine, a cytotoxic 
131 
metabolite of some pyrrolizidine alkaloids: an in vitro test. Toxicol Lett, 16, 1-8。 
M A T T O C K S , A.R. & JUKES, R. (1990a). Trapping and measurement of short-lived 
alkylating agents in a recirculating flow system. Chem Biol Interact, 76, 19-30. 
M A T T O C K S , A.R. & JUKES, R. (1990b). Recovery of the pyrrolic nucleus of 
pyrrolizidine alkaloid metabolites from sulphur conjugates in tissues and body fluids. 
Chem Biol Interact, 75, 225-239. 
M A T T O C K S , A.R. & JUKES, R. (1992). Chemistry of sulphur-bound pyrrolic 
metabolites in the blood of rats given different types of pyrrolizidine alkaloid. Nat 
Toxins, 1, 89-95. 
M C L E A N , E.K., & M A T T O C K S , A.R. (1980). Toxic injury of the liver, Dekker, NY. 
Medicines and Healthcare products Regulatory Agency. 2002: Statement concerning 
Senecio containing Qianbai Biyan Pian [monograph on the Internet]. London (United 
Kingdom): The Agency; c2007 [updated 2002 Mar 26; cited 2007 Sept 3]. Available 
from: http://www.mhra.gov.iik/liome/idcplg?IdcService=GET_FILE&dID=2996&no 
SaveAs=0&Rendition=WEB. 2004: Consultation letter M L X 296: Proposals to 
prohibit the sale, supply or importation of unlicensed herbal medicinal products for 
internal use which contain Senecio species [monograph on the Internet]. London 
(United Kingdom): The Agency; c2007 [updated 2004 Jan 29; cited 2007 Sept 3]. 
Available from: http://www.mhra.gov.uk/home/idcplg?IdcService=SS_GET_PAGE 
& i i s e S e c o n d a r y = t m e&ssDocName=C〇N 1004416&ssTargetNodeId=373. 2007: 
Public consultation: Proposals to prohibit the sale, supply or importation of 
unlicensed medicinal products for internal use which contain Senecio species and 
proposals to amend three existing orders [monograph on the Internet]. London 





M I R A N D A , CL., C H U N G , W., R E E D , R.E., Z H A O , X.,HENDERSON, M.C., 
W A N G , J.L., W I L L I A M S , D.E. & B U H L E R , D.R. (1991). Flavin-containmg 
monooxygenase: a major detoxifying enzyme for the pyrrolizidine alkaloid 
senecionine in guinea pig tissues. Biochem Biophys Res Commun, 178, 546-552. 
M R O C Z E K , T., G L O W N I A K , K. & W L A S Z C Z Y K , A. (2002). Simultaneous 
determination of N-oxides and free bases of pyrrolizidine alkaloids by 
cation-exchange solid-phase extraction and ion-pair high-performance liquid 
chromatography. J Chromatogr A, 949, 249-262. 
M U L L E R , L., K A S P E R , P. & K A U F M A N N , G. (1992). The clastogenic potential in 
vitro of pyrrolizidine alkaloids employing hepatocyte metabolism. Mutat Res, 282, 
169-176. 
O Z E R , J., R A T N E R , M., S H A W , M., BAILEY, W . & S C H O M A K E R , S. (2008). The 
current state of serum biomarkers of hepatotoxicity. Toxicology, 245, 194-205. 
PETRY, T.W., B O W D E N , G.T., H U X T A B L E , R.J. & SIPES, 1. G. (1984). 
Characterization of hepatic D N A damage induced in rats by the pyrrolizidine 
alkaloid monocrotaline. Cancer Res, 44, 1505-1509. 
P R A K A S H , A.S., PEREIRA, T.N., REILLY, RE. & S E A W R I G H T , A.A. (1999). 
Pyrrolizidine alkaloids in human diet. Mutat Res 443, 53-67, 
R A S E N A C K , R., M U L L E R , C., KLEINSCHMIDT, M., R A S E N A C K , J. & 
W I E D E N F E L D , H. (2003). Veno-occlusive disease in a fetus caused by pyrrolizidine 
alkaloids of food origin. Fetal Diagn Ther 18, 223-225. 
R O B E R T S O N , K.A., S E Y M O U R , LL., HSIA, M.T. & A L L E N , J.R. (1977). 
Covalent interaction of dehydroretronecine, a carcinogenic metabolite of the 
pyrrolizidine alkaloid monocrotaline, with cysteine and glutathione. Cancer Res, 37, 
3141-3144. 
133 
R O D E R , E., LIANG, X.T. & K A B U S , K.J. (1992). Pyrrolizidine Alkaloids from the 
Seeds of Crotalaria sessiliflora. Planta Med, 58, 283. 
R O E D E R , E. (1995). Medicinal plants in Europe containing pyrrolizidine alkaloids. 
Pharmazie, 50, 83-98. 
R O E D E R , E. (2000). Medicinal plants in China containing pyrrolizidine alkaloids. 
Pharmazie, 55, 711-726. 
S I G M A DIAGNOSTICS, Transaminases kit for (ALT/GPT and AST/GOT) No.505 
manual. 
S T E E N K A M P , V., S T E W A R T , M.J. & Z U C K E R M A N , M . (2000). Clinical and 
analytical aspects of pyrrolizidine poisoning caused by South African traditional 
medicines. Ther Drug Monit, 22, 302-306。 
STEGELMEIER, B.L., E D G A R , J.A., C O L E G A T E , S.M., G A R D N E R , D.R. & 
S C H O C H , T.K. (1999). Pyrrolizidine alkaloid plants, metabolism and toxicity. J Nat 
Toxins, 8, 95-116. 
TANG, J., A K A O , T., N A K A M U R A , N., W A N G , Z.T., T A K A G A W A , K., 
S A S A H A R A , M . & HATTORJ, M . (2007). In vitro metabolism of isoline, a 
pyrrolizidine alkaloid from ligularia duciformis, by rodent liver microsomal esterase 
and enhanced hepatotoxicity by esterase inhibitors. Drug Metab Dispos, 35, 
1832-1839. 
T R E M L E T T , H. & O G E R , J. (2004). Hepatic injury, liver monitoring and the 
beta-interferons for multiple sclerosis. J Neurol, 251, 1297-1303. 
U Z U N , E., SARIYAR, G , A D S E R S E N , A., K A R A K O C , B., OTiiK, G , 
O K T A Y O G L U , E. & PIRJLDAR, S. (2004). Traditional medicine in Sakarya 
province (Turkey) and antimicrobial activities of selected species. J Ethnopharmacol, 
95, 287-296. 
134 
W A L L A C E , K., BURT, A.D. & W R I G H T , M.C. (2008). Liver fibrosis. Biochem J, 
411， 1-18. 
W H I T E , I.N. (1976). The role of liver glutathione in the acute toxicity of retrorsine 
to rats. Chem Biol Interact, 13, 333-342. 
W H I T E , I.N.，MATTOCKS, A.R. & B U H L E R , W.H. (1973). The conversion of the 
pyrrolizidine alkaloid retrorsine to pyrrolic derivatives in vivo and in vitro and its 
acute toxicity to various animal species. Chem Biol Interact, 6, 207-218. 
W I L L I A M S , D.E., R E E D , R丄.，KEDZIERSKI, B., ZIEGLER, D.M. & B U H L E R , 
D.R. (1989). The role of flavin-containing monooxygenase in the TV-oxidation of the 
pyrrolizidine alkaloid senecionine. Drug Metab Dispos, 17, 380-386. 
W I L L M O T , F.C. & R O B E R T S O N , G W . (1920). Senecio disease, or cirrhosis of the 
liver due to senecio poisoning. Lancet, 2, 848-849. 
XIA, Q., C H O U , M.W., K A D L U B A R , F.R, C H A N , RC. & FU, P.P. (2003). Human 
liver microsomal metabolism and D N A adduct formation of the tumorigenic 
pyrrolizidine alkaloid, reddelliine. Chem Res Toxicol, 16, 66-73, 
Y A N , C.C. & H U X T A B L E , R.J. (1994). Quantitation of the hepatic release of 
metabolites of the pyrrolizidine alkaloid, monocrotaline. Toxicol Appl Pharmacol, 
127, 58-63. 
Y A N , C.C. & H U X T A B L E , RJ. (1995). The effect of the pyrrolizidine alkaloids, 
monocrotaline and trichodesmine, on tissue pyrrole binding and glutathione 
metabolism in the rat. Toxicon, 33, 627-634. 
Y A N , C.C. & H U X T A B L E , R.J. (1996). Effects of monocrotaline, a pyrrolizidine 
alkaloid, on glutathione metabolism in the rat. Biochem Pharmacol, 51, 375-379. 
Y U A N , S.Q., G U , G.M. & WEI, T.T. (1990). Studies on the alkaloids of Gynura 
135 
segetum (Lour.) Merr. Yao Xue Xue Bao, 25, 191-197. 
Z H A O , X.G, Z H A N G , M., LI, Z.M., W A N G , Z.T., X U , L.S., X U , G.J., Y U , G D . & 
LIN, G. (2000). Investigation into the Chinese traditional drug, Zi Wan, Chapter 3 in 
Species Systematization and Quality Evaluation of Commonly Used Chinese 






C U H K L i b r a r i e s 
0 0 4 5 6 1 4 9 9 
I 
